The role of pyroptosis in cancer: pro-cancer or pro-“host”?
Programmed cell death (PCD) refers to the way in which cells die depending on specific genes encoding signals or activities. Apoptosis, autophagy, and pyroptosis are all mechanisms of PCD. Among these mechanisms, pyroptosis is mediated by the gasdermin family, accompanied by inflammatory and immune...
Uloženo v:
| Vydáno v: | Cell death & disease Ročník 10; číslo 9; s. 650 - 13 |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
Nature Publishing Group UK
09.09.2019
Springer Nature B.V |
| Témata: | |
| ISSN: | 2041-4889, 2041-4889 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Programmed cell death (PCD) refers to the way in which cells die depending on specific genes encoding signals or activities. Apoptosis, autophagy, and pyroptosis are all mechanisms of PCD. Among these mechanisms, pyroptosis is mediated by the gasdermin family, accompanied by inflammatory and immune responses. The relationship between pyroptosis and cancer is complex, and the effects of pyroptosis on cancer vary in different tissues and genetic backgrounds. On one hand, pyroptosis can inhibit the occurrence and development of tumors; on the other hand, as a type of proinflammatory death, pyroptosis can form a suitable microenvironment for tumor cell growth and thus promote tumor growth. In addition, the induction of tumor pyroptosis is also considered a potential cancer treatment strategy. Studies have shown that DFNA5 (nonsyndromic hearing impairment protein 5)/GSDME (Gasdermin-E) mRNA methylation results in lower expression levels of DFNA5/GSDME in most tumor cells than in normal cells, making it difficult to activate the pyroptosis in most tumor cells. During the treatment of malignant tumors, appropriate chemotherapeutic drugs can be selected according to the expression levels of DFNA5/GSDME, which can be upregulated in tumor cells, thereby increasing the sensitivity to chemotherapeutic drugs and reducing drug resistance. Therefore, induced pyroptosis may play a predominant role in the treatment of cancer. Here, we review the latest research on the anti- and protumor effects of pyroptosis and its potential applications in cancer treatment. |
|---|---|
| AbstractList | Programmed cell death (PCD) refers to the way in which cells die depending on specific genes encoding signals or activities. Apoptosis, autophagy, and pyroptosis are all mechanisms of PCD. Among these mechanisms, pyroptosis is mediated by the gasdermin family, accompanied by inflammatory and immune responses. The relationship between pyroptosis and cancer is complex, and the effects of pyroptosis on cancer vary in different tissues and genetic backgrounds. On one hand, pyroptosis can inhibit the occurrence and development of tumors; on the other hand, as a type of proinflammatory death, pyroptosis can form a suitable microenvironment for tumor cell growth and thus promote tumor growth. In addition, the induction of tumor pyroptosis is also considered a potential cancer treatment strategy. Studies have shown that DFNA5 (nonsyndromic hearing impairment protein 5)/GSDME (Gasdermin-E) mRNA methylation results in lower expression levels of DFNA5/GSDME in most tumor cells than in normal cells, making it difficult to activate the pyroptosis in most tumor cells. During the treatment of malignant tumors, appropriate chemotherapeutic drugs can be selected according to the expression levels of DFNA5/GSDME, which can be upregulated in tumor cells, thereby increasing the sensitivity to chemotherapeutic drugs and reducing drug resistance. Therefore, induced pyroptosis may play a predominant role in the treatment of cancer. Here, we review the latest research on the anti- and protumor effects of pyroptosis and its potential applications in cancer treatment.Programmed cell death (PCD) refers to the way in which cells die depending on specific genes encoding signals or activities. Apoptosis, autophagy, and pyroptosis are all mechanisms of PCD. Among these mechanisms, pyroptosis is mediated by the gasdermin family, accompanied by inflammatory and immune responses. The relationship between pyroptosis and cancer is complex, and the effects of pyroptosis on cancer vary in different tissues and genetic backgrounds. On one hand, pyroptosis can inhibit the occurrence and development of tumors; on the other hand, as a type of proinflammatory death, pyroptosis can form a suitable microenvironment for tumor cell growth and thus promote tumor growth. In addition, the induction of tumor pyroptosis is also considered a potential cancer treatment strategy. Studies have shown that DFNA5 (nonsyndromic hearing impairment protein 5)/GSDME (Gasdermin-E) mRNA methylation results in lower expression levels of DFNA5/GSDME in most tumor cells than in normal cells, making it difficult to activate the pyroptosis in most tumor cells. During the treatment of malignant tumors, appropriate chemotherapeutic drugs can be selected according to the expression levels of DFNA5/GSDME, which can be upregulated in tumor cells, thereby increasing the sensitivity to chemotherapeutic drugs and reducing drug resistance. Therefore, induced pyroptosis may play a predominant role in the treatment of cancer. Here, we review the latest research on the anti- and protumor effects of pyroptosis and its potential applications in cancer treatment. Programmed cell death (PCD) refers to the way in which cells die depending on specific genes encoding signals or activities. Apoptosis, autophagy, and pyroptosis are all mechanisms of PCD. Among these mechanisms, pyroptosis is mediated by the gasdermin family, accompanied by inflammatory and immune responses. The relationship between pyroptosis and cancer is complex, and the effects of pyroptosis on cancer vary in different tissues and genetic backgrounds. On one hand, pyroptosis can inhibit the occurrence and development of tumors; on the other hand, as a type of proinflammatory death, pyroptosis can form a suitable microenvironment for tumor cell growth and thus promote tumor growth. In addition, the induction of tumor pyroptosis is also considered a potential cancer treatment strategy. Studies have shown that DFNA5 (nonsyndromic hearing impairment protein 5)/GSDME (Gasdermin-E) mRNA methylation results in lower expression levels of DFNA5/GSDME in most tumor cells than in normal cells, making it difficult to activate the pyroptosis in most tumor cells. During the treatment of malignant tumors, appropriate chemotherapeutic drugs can be selected according to the expression levels of DFNA5/GSDME, which can be upregulated in tumor cells, thereby increasing the sensitivity to chemotherapeutic drugs and reducing drug resistance. Therefore, induced pyroptosis may play a predominant role in the treatment of cancer. Here, we review the latest research on the anti- and protumor effects of pyroptosis and its potential applications in cancer treatment. |
| ArticleNumber | 650 |
| Author | Jiang, Jinqing Cheng, Zhe Wang, Xin Qin, Wanhai Xia, Xiaojing Lei, Liancheng Hu, Jianhe |
| Author_xml | – sequence: 1 givenname: Xiaojing orcidid: 0000-0001-7717-8411 surname: Xia fullname: Xia, Xiaojing email: quik500@163.com organization: College of Animal Science and Veterinary Medicine, Henan Institute of Science and Technology – sequence: 2 givenname: Xin surname: Wang fullname: Wang, Xin organization: College of Agriculture and Forestry Science, Linyi University – sequence: 3 givenname: Zhe surname: Cheng fullname: Cheng, Zhe organization: College of Animal Science and Veterinary Medicine, Henan Institute of Science and Technology – sequence: 4 givenname: Wanhai surname: Qin fullname: Qin, Wanhai organization: Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam Infection and Immunity – sequence: 5 givenname: Liancheng surname: Lei fullname: Lei, Liancheng organization: College of Veterinary Medicine, Jilin University – sequence: 6 givenname: Jinqing surname: Jiang fullname: Jiang, Jinqing organization: College of Animal Science and Veterinary Medicine, Henan Institute of Science and Technology – sequence: 7 givenname: Jianhe surname: Hu fullname: Hu, Jianhe organization: College of Animal Science and Veterinary Medicine, Henan Institute of Science and Technology |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31501419$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UctKAzEUDVKxWvsBbmTAjZvRPGY6iQuLFF8guOk-ZDKZNmWajMlU6K4foj_XLzF1fBY0cMkN95zDyT0HoGOsUQAcIXiGIKHnPkEJYjEMhSglMd0B-xgmKE4oZZ0ffRf0vZ_BcAiBOB3sgS5BKdyw98FwPFWRs5WKbBnVS2frxnrtI20iKYxU7iKqnY3bPrLu_bVevUytb9ar1-Eh2C1F5VX_4-6B8c31eHQXPzze3o-uHmKZkkET5ygtkhLjguWQ5bgoBqlEuUhLkUCUK0hYliZ5gUkmmFCQsYyqUsAMC4lzrEgPXLay9SKfq0Iq0zhR8drpuXBLboXmvydGT_nEPvNBRgiDKAicfgg4-7RQvuFz7aWqKmGUXXiOMaVhQSkhAXqyBZ3ZhTPhdxwTmNCgSFhAHf909GXlc7UBkLUA6az3TpVc6kY02m4M6oojyDc58jZHHnLkmxw5DUy0xfwU_4-DW44PWDNR7tv036Q3YPOwLg |
| CitedBy_id | crossref_primary_10_3389_fcell_2021_748039 crossref_primary_10_3390_life11040332 crossref_primary_10_1038_s41375_022_01662_6 crossref_primary_10_1080_07357907_2021_1991944 crossref_primary_10_1007_s10495_023_01906_5 crossref_primary_10_3389_fsurg_2022_837848 crossref_primary_10_1007_s00018_025_05666_0 crossref_primary_10_3390_cancers13194753 crossref_primary_10_1038_s41420_024_02178_x crossref_primary_10_1158_2159_8290_CD_20_0805 crossref_primary_10_3390_ph16060783 crossref_primary_10_5306_wjco_v15_i8_968 crossref_primary_10_3390_cells13201699 crossref_primary_10_1186_s40001_023_01581_x crossref_primary_10_1016_j_ebiom_2024_105420 crossref_primary_10_1038_s41598_022_05599_9 crossref_primary_10_1038_s41598_022_15373_6 crossref_primary_10_1186_s12967_023_04513_9 crossref_primary_10_3390_genes12101535 crossref_primary_10_1016_j_phrs_2023_106660 crossref_primary_10_1038_s41590_021_00869_6 crossref_primary_10_1186_s12885_023_11757_7 crossref_primary_10_3389_fonc_2021_635774 crossref_primary_10_1186_s12885_020_06964_5 crossref_primary_10_3389_fonc_2022_845074 crossref_primary_10_1155_2022_6402599 crossref_primary_10_2147_PGPM_S424326 crossref_primary_10_1038_s41598_023_43023_y crossref_primary_10_3892_mmr_2023_13039 crossref_primary_10_2147_JIR_S338584 crossref_primary_10_3389_fphar_2021_788874 crossref_primary_10_3389_fimmu_2022_933703 crossref_primary_10_3389_fcell_2021_761350 crossref_primary_10_3389_fimmu_2021_748221 crossref_primary_10_1007_s00405_023_08022_9 crossref_primary_10_3390_cancers13020304 crossref_primary_10_3389_fimmu_2022_1052111 crossref_primary_10_3389_fonc_2021_716854 crossref_primary_10_1016_j_snb_2024_136367 crossref_primary_10_3389_fbioe_2022_852734 crossref_primary_10_1007_s12032_025_02766_6 crossref_primary_10_1089_ars_2023_0257 crossref_primary_10_1186_s12920_023_01590_z crossref_primary_10_20517_2394_4722_2025_18 crossref_primary_10_3389_fcell_2021_811734 crossref_primary_10_3389_fmolb_2022_822503 crossref_primary_10_3390_biom12070924 crossref_primary_10_3389_fgene_2022_963565 crossref_primary_10_1007_s10495_025_02161_6 crossref_primary_10_1155_2022_7043431 crossref_primary_10_3389_fendo_2022_1003594 crossref_primary_10_1007_s12033_023_00757_4 crossref_primary_10_1038_s41419_021_03458_5 crossref_primary_10_3389_fcell_2022_840576 crossref_primary_10_3389_fimmu_2023_1236063 crossref_primary_10_3389_fimmu_2021_717850 crossref_primary_10_1002_ange_202508544 crossref_primary_10_3389_fphar_2022_806995 crossref_primary_10_1007_s00432_023_05074_6 crossref_primary_10_1097_MD_0000000000036605 crossref_primary_10_1016_j_prp_2024_155224 crossref_primary_10_1007_s10787_023_01275_0 crossref_primary_10_1186_s12859_022_04726_7 crossref_primary_10_1007_s12031_023_02104_3 crossref_primary_10_1007_s12274_022_4811_7 crossref_primary_10_3390_cells11030394 crossref_primary_10_3389_fonc_2021_709077 crossref_primary_10_1016_j_psj_2025_105269 crossref_primary_10_1158_0008_5472_CAN_22_1812 crossref_primary_10_1186_s12935_021_02231_0 crossref_primary_10_3390_life13071599 crossref_primary_10_1186_s12964_023_01458_w crossref_primary_10_3389_fimmu_2023_1111494 crossref_primary_10_3390_ijms231810494 crossref_primary_10_1002_anie_202508544 crossref_primary_10_1002_mog2_26 crossref_primary_10_3389_fcell_2021_742994 crossref_primary_10_1097_MD_0000000000031043 crossref_primary_10_1167_iovs_66_1_24 crossref_primary_10_1186_s41065_023_00288_7 crossref_primary_10_1016_j_heliyon_2024_e34360 crossref_primary_10_1016_j_tranon_2025_102342 crossref_primary_10_1007_s13105_022_00909_1 crossref_primary_10_1186_s13045_020_00946_7 crossref_primary_10_1002_ange_202010281 crossref_primary_10_1016_j_bioactmat_2022_08_016 crossref_primary_10_1016_j_intimp_2023_110143 crossref_primary_10_3389_fonc_2022_1013544 crossref_primary_10_3389_fgene_2022_817919 crossref_primary_10_3389_fonc_2022_779168 crossref_primary_10_3892_ijo_2023_5548 crossref_primary_10_1016_j_abb_2024_109923 crossref_primary_10_1155_2022_1803544 crossref_primary_10_1186_s10020_022_00445_0 crossref_primary_10_3389_fimmu_2022_803355 crossref_primary_10_1016_j_cmet_2022_03_003 crossref_primary_10_1016_j_tranon_2025_102454 crossref_primary_10_1111_cpr_13137 crossref_primary_10_1155_2021_5074305 crossref_primary_10_3389_fonc_2022_1015850 crossref_primary_10_5306_wjco_v16_i4_104061 crossref_primary_10_1007_s00432_023_05018_0 crossref_primary_10_1002_cam4_5344 crossref_primary_10_1002_cbdv_202401873 crossref_primary_10_1515_med_2023_0663 crossref_primary_10_3389_fimmu_2022_965469 crossref_primary_10_1167_iovs_64_1_4 crossref_primary_10_1007_s11033_023_08482_6 crossref_primary_10_1016_j_cbi_2021_109434 crossref_primary_10_1039_D5DT01235J crossref_primary_10_1111_cpr_13376 crossref_primary_10_3389_fmolb_2022_890215 crossref_primary_10_1007_s12032_023_02293_2 crossref_primary_10_3390_biomedicines11102792 crossref_primary_10_1186_s12935_023_02897_8 crossref_primary_10_1016_j_cbi_2025_111693 crossref_primary_10_1038_s41467_024_52553_6 crossref_primary_10_3892_ijmm_2023_5272 crossref_primary_10_1155_2022_7931393 crossref_primary_10_1016_j_lfs_2023_121498 crossref_primary_10_1016_j_semcdb_2020_08_011 crossref_primary_10_1038_s41420_023_01421_1 crossref_primary_10_3389_fmolb_2022_815290 crossref_primary_10_1007_s12672_024_01579_9 crossref_primary_10_1016_j_jconrel_2023_02_042 crossref_primary_10_1080_07853890_2024_2394584 crossref_primary_10_1016_j_biopha_2022_113675 crossref_primary_10_2147_JIR_S478989 crossref_primary_10_1007_s12672_025_02592_2 crossref_primary_10_3389_fphar_2022_952587 crossref_primary_10_3390_cells12040659 crossref_primary_10_1097_JN9_0000000000000035 crossref_primary_10_1016_j_intimp_2022_108802 crossref_primary_10_1002_adhm_202302606 crossref_primary_10_1080_02713683_2022_2048396 crossref_primary_10_3389_fimmu_2022_932303 crossref_primary_10_3389_fmolb_2022_871602 crossref_primary_10_1097_MD_0000000000031599 crossref_primary_10_3390_cancers14061546 crossref_primary_10_3389_fimmu_2023_1074606 crossref_primary_10_1134_S0026893324060049 crossref_primary_10_2217_epi_2023_0139 crossref_primary_10_1002_cam4_7303 crossref_primary_10_1002_cnr2_1561 crossref_primary_10_1155_2022_6429993 crossref_primary_10_1515_med_2023_0886 crossref_primary_10_1155_2022_6905588 crossref_primary_10_3389_fgene_2022_1034606 crossref_primary_10_1111_cas_15384 crossref_primary_10_3390_biomedicines12030559 crossref_primary_10_1155_2021_6365459 crossref_primary_10_1038_s41598_025_97727_4 crossref_primary_10_1186_s40001_024_02201_y crossref_primary_10_1186_s12890_023_02408_5 crossref_primary_10_1016_j_bbi_2024_02_001 crossref_primary_10_3389_fphar_2022_951480 crossref_primary_10_1038_s41420_024_02285_9 crossref_primary_10_1017_erm_2022_37 crossref_primary_10_3389_fcell_2021_766503 crossref_primary_10_3389_fgene_2022_929870 crossref_primary_10_1007_s11060_024_04750_y crossref_primary_10_3389_fonc_2022_770005 crossref_primary_10_3389_fgene_2021_773373 crossref_primary_10_3389_fendo_2023_1120216 crossref_primary_10_3390_biomedicines13010134 crossref_primary_10_3389_fcell_2021_705828 crossref_primary_10_3389_fphar_2023_1228985 crossref_primary_10_3892_ol_2024_14835 crossref_primary_10_1080_1120009X_2023_2278014 crossref_primary_10_1038_s41435_025_00333_7 crossref_primary_10_2147_JIR_S291453 crossref_primary_10_3389_fgene_2022_926796 crossref_primary_10_3389_fcell_2021_727183 crossref_primary_10_3389_fimmu_2022_933779 crossref_primary_10_26599_NTM_2022_9130001 crossref_primary_10_3389_fonc_2022_861284 crossref_primary_10_1097_MD_0000000000033075 crossref_primary_10_1038_s41420_024_01832_8 crossref_primary_10_3389_fgene_2022_801419 crossref_primary_10_1016_j_apsb_2024_11_011 crossref_primary_10_2147_IDR_S292413 crossref_primary_10_3389_fphar_2023_1122104 crossref_primary_10_3390_cells11243980 crossref_primary_10_1155_2022_8093837 crossref_primary_10_1016_j_intimp_2021_108270 crossref_primary_10_1155_2024_2217335 crossref_primary_10_1007_s10787_023_01148_6 crossref_primary_10_3389_fphar_2023_1159409 crossref_primary_10_1002_advs_202207456 crossref_primary_10_1016_j_wneu_2021_12_042 crossref_primary_10_3389_fsurg_2022_903271 crossref_primary_10_1007_s12672_024_01691_w crossref_primary_10_2147_JIR_S422585 crossref_primary_10_1111_imr_13301 crossref_primary_10_1155_2021_9916796 crossref_primary_10_1007_s12010_024_05113_z crossref_primary_10_1007_s10142_023_01103_2 crossref_primary_10_2147_IJGM_S331975 crossref_primary_10_3389_fonc_2023_1170336 crossref_primary_10_1016_j_cyto_2022_155925 crossref_primary_10_1016_j_heliyon_2022_e11035 crossref_primary_10_3390_cells11071078 crossref_primary_10_1155_2022_1539659 crossref_primary_10_1016_j_bbrc_2025_152550 crossref_primary_10_1177_09287329241296358 crossref_primary_10_3892_ol_2025_14948 crossref_primary_10_3389_fonc_2022_885114 crossref_primary_10_1016_j_ygeno_2022_110355 crossref_primary_10_1155_2022_4944758 crossref_primary_10_1515_oncologie_2023_0045 crossref_primary_10_1016_j_omtn_2022_01_018 crossref_primary_10_2147_JIR_S319213 crossref_primary_10_1038_s41598_025_06756_6 crossref_primary_10_1007_s11864_023_01119_7 crossref_primary_10_1016_j_aquaculture_2025_742571 crossref_primary_10_1016_j_jep_2022_115560 crossref_primary_10_3389_fonc_2022_932786 crossref_primary_10_3389_fgene_2022_809587 crossref_primary_10_1016_j_apsb_2025_05_021 crossref_primary_10_1186_s12964_023_01083_7 crossref_primary_10_1016_j_xnsj_2023_100210 crossref_primary_10_1038_s41598_024_77409_3 crossref_primary_10_3389_fonc_2023_1085188 crossref_primary_10_1186_s12920_022_01359_w crossref_primary_10_1016_j_critrevonc_2023_104249 crossref_primary_10_62347_VZAW2270 crossref_primary_10_1186_s12943_022_01710_w crossref_primary_10_1002_adfm_202412040 crossref_primary_10_1038_s41392_022_01046_3 crossref_primary_10_1111_raq_12533 crossref_primary_10_1021_jacs_4c01929 crossref_primary_10_3390_cells9122709 crossref_primary_10_2147_IJGM_S353762 crossref_primary_10_1007_s43657_024_00173_x crossref_primary_10_3389_fonc_2021_697198 crossref_primary_10_1002_jbt_23614 crossref_primary_10_2147_IJGM_S335073 crossref_primary_10_1016_j_biomaterials_2024_122894 crossref_primary_10_3389_fonc_2022_717926 crossref_primary_10_1038_s41419_025_07866_9 crossref_primary_10_1038_s41467_023_39938_9 crossref_primary_10_3390_ijms23116178 crossref_primary_10_1111_cas_15645 crossref_primary_10_7717_peerj_17296 crossref_primary_10_1016_j_intimp_2024_113492 crossref_primary_10_1038_s41598_024_66662_1 crossref_primary_10_1007_s12672_024_01315_3 crossref_primary_10_3389_fphar_2022_848939 crossref_primary_10_3389_fimmu_2022_854785 crossref_primary_10_3389_fcell_2022_948097 crossref_primary_10_3389_fmed_2021_702638 crossref_primary_10_1155_2022_9046507 crossref_primary_10_1097_MD_0000000000033150 crossref_primary_10_1016_j_jare_2025_07_011 crossref_primary_10_1016_j_surfin_2024_104147 crossref_primary_10_1038_s41392_023_01502_8 crossref_primary_10_1002_msp2_53 crossref_primary_10_1038_s42003_022_03806_x crossref_primary_10_1111_pcmr_12870 crossref_primary_10_1155_2022_5925817 crossref_primary_10_3389_fgene_2022_843538 crossref_primary_10_1002_ange_202501530 crossref_primary_10_1007_s10787_023_01379_7 crossref_primary_10_1016_j_neo_2021_03_010 crossref_primary_10_3389_fimmu_2023_1290885 crossref_primary_10_1002_cam4_4898 crossref_primary_10_1080_21655979_2021_2019873 crossref_primary_10_1002_adhm_202301266 crossref_primary_10_1158_2326_6066_CIR_19_0974 crossref_primary_10_1016_j_intimp_2021_108236 crossref_primary_10_1016_j_bbcan_2023_189058 crossref_primary_10_3389_fgene_2022_851384 crossref_primary_10_1038_s41420_021_00451_x crossref_primary_10_1007_s11010_024_05147_1 crossref_primary_10_3390_biomedicines10123084 crossref_primary_10_1016_j_wneu_2023_07_134 crossref_primary_10_3389_fgene_2022_809794 crossref_primary_10_1155_2023_4256116 crossref_primary_10_1016_j_it_2021_05_001 crossref_primary_10_1186_s12920_022_01322_9 crossref_primary_10_2147_JIR_S349186 crossref_primary_10_3390_ijms23116198 crossref_primary_10_1038_s41417_020_0200_0 crossref_primary_10_3389_fonc_2024_1442237 crossref_primary_10_1155_2022_6965308 crossref_primary_10_3389_fgene_2022_922055 crossref_primary_10_1007_s11010_025_05279_y crossref_primary_10_1007_s11033_021_06252_w crossref_primary_10_1186_s40364_022_00433_w crossref_primary_10_1093_ibd_izab217 crossref_primary_10_3389_fmed_2022_882763 crossref_primary_10_3892_ol_2023_13962 crossref_primary_10_1177_00220345211073072 crossref_primary_10_3389_fgene_2022_900159 crossref_primary_10_3389_fgene_2022_865204 crossref_primary_10_1038_s41419_022_04851_4 crossref_primary_10_3389_fonc_2022_837155 crossref_primary_10_1016_j_hbpd_2024_09_010 crossref_primary_10_1002_adma_202206510 crossref_primary_10_1016_j_gastha_2024_09_007 crossref_primary_10_3390_cells13131083 crossref_primary_10_3389_fcell_2022_826879 crossref_primary_10_1007_s12282_023_01437_6 crossref_primary_10_1016_j_tranon_2023_101693 crossref_primary_10_1016_j_isci_2023_107762 crossref_primary_10_3389_fmolb_2022_850758 crossref_primary_10_15252_embj_2022112573 crossref_primary_10_1186_s12935_022_02729_1 crossref_primary_10_3389_fimmu_2025_1617036 crossref_primary_10_1186_s13045_022_01392_3 crossref_primary_10_3389_fcell_2022_912008 crossref_primary_10_1016_j_ecoenv_2024_117441 crossref_primary_10_3389_fimmu_2022_845757 crossref_primary_10_1155_2022_3625790 crossref_primary_10_1186_s12943_025_02344_4 crossref_primary_10_1007_s12013_023_01181_w crossref_primary_10_2147_IJGM_S352062 crossref_primary_10_1136_bmjresp_2023_002089 crossref_primary_10_3389_fmed_2022_934835 crossref_primary_10_3389_fgene_2022_1029717 crossref_primary_10_1016_j_chembiol_2024_07_003 crossref_primary_10_31083_j_fbl2810235 crossref_primary_10_3389_fonc_2021_706266 crossref_primary_10_1038_s41586_020_2071_9 crossref_primary_10_1016_j_canlet_2023_216413 crossref_primary_10_1038_s41419_023_06382_y crossref_primary_10_1111_jcmm_16574 crossref_primary_10_1007_s11010_022_04502_4 crossref_primary_10_1007_s10495_023_01823_7 crossref_primary_10_3389_fcell_2022_814722 crossref_primary_10_3389_fcell_2023_1295891 crossref_primary_10_1016_j_heliyon_2023_e21503 crossref_primary_10_3389_fimmu_2024_1400977 crossref_primary_10_1038_s41598_022_15348_7 crossref_primary_10_1186_s13048_023_01225_y crossref_primary_10_1016_j_bioorg_2025_108310 crossref_primary_10_1186_s12950_022_00316_9 crossref_primary_10_3390_vaccines9020138 crossref_primary_10_1186_s12920_022_01172_5 crossref_primary_10_1186_s12943_024_02183_9 crossref_primary_10_1080_08830185_2021_1876044 crossref_primary_10_1002_cam4_70081 crossref_primary_10_3389_fphar_2022_1050774 crossref_primary_10_1016_j_freeradbiomed_2025_02_002 crossref_primary_10_3389_fonc_2021_755212 crossref_primary_10_3389_fonc_2022_814912 crossref_primary_10_1016_j_biopha_2024_116815 crossref_primary_10_1186_s13048_022_01065_2 crossref_primary_10_3389_fonc_2022_991165 crossref_primary_10_1038_s41419_022_04808_7 crossref_primary_10_1097_MD_0000000000035195 crossref_primary_10_1093_ntr_ntaf140 crossref_primary_10_1007_s12672_022_00474_5 crossref_primary_10_1038_s41392_020_0180_4 crossref_primary_10_3389_fimmu_2022_974916 crossref_primary_10_3389_fonc_2023_1163714 crossref_primary_10_3390_diagnostics12112858 crossref_primary_10_3389_fonc_2022_890242 crossref_primary_10_1186_s12920_022_01339_0 crossref_primary_10_3389_fcell_2022_844013 crossref_primary_10_3389_fonc_2023_1277639 crossref_primary_10_3389_fcell_2021_676485 crossref_primary_10_1016_j_bbrc_2025_151972 crossref_primary_10_1016_j_bbagen_2024_130602 crossref_primary_10_3390_antiox12081551 crossref_primary_10_1002_mc_23767 crossref_primary_10_1016_j_omtn_2023_07_010 crossref_primary_10_2147_JIR_S498703 crossref_primary_10_1186_s12920_023_01431_z crossref_primary_10_1007_s12035_022_03010_2 crossref_primary_10_1002_adma_202309488 crossref_primary_10_3390_ijms242015484 crossref_primary_10_1016_j_tranon_2023_101770 crossref_primary_10_1002_advs_202203583 crossref_primary_10_1155_2021_8175003 crossref_primary_10_1155_2022_4494713 crossref_primary_10_1038_s41420_022_01101_6 crossref_primary_10_1016_j_jtcme_2023_10_004 crossref_primary_10_1038_s44321_024_00068_4 crossref_primary_10_3390_ijms23020943 crossref_primary_10_1016_j_nantod_2022_101740 crossref_primary_10_3390_cancers14020447 crossref_primary_10_1016_j_imbio_2022_152261 crossref_primary_10_2147_IJGM_S353576 crossref_primary_10_1042_BSR20221053 crossref_primary_10_3390_cancers12102952 crossref_primary_10_2147_IJGM_S337089 crossref_primary_10_2147_IJGM_S338298 crossref_primary_10_1097_MD_0000000000029710 crossref_primary_10_3389_fgene_2022_1074723 crossref_primary_10_1186_s41016_024_00366_3 crossref_primary_10_31083_j_fbl2812334 crossref_primary_10_1142_S0192415X24500903 crossref_primary_10_2147_JIR_S277457 crossref_primary_10_1097_MD_0000000000039300 crossref_primary_10_1016_j_wneu_2023_06_043 crossref_primary_10_3390_biomedicines10050974 crossref_primary_10_1155_2022_4534080 crossref_primary_10_1002_cam4_4825 crossref_primary_10_3389_fimmu_2022_991044 crossref_primary_10_3389_fcell_2021_770301 crossref_primary_10_1016_j_intimp_2025_114560 crossref_primary_10_3892_ijo_2024_5610 crossref_primary_10_3389_fgene_2022_975185 crossref_primary_10_3389_fimmu_2022_939978 crossref_primary_10_3389_fcell_2021_779123 crossref_primary_10_1002_mco2_249 crossref_primary_10_1016_j_heliyon_2024_e28493 crossref_primary_10_3390_cells9081823 crossref_primary_10_1111_imr_13294 crossref_primary_10_1186_s12935_022_02476_3 crossref_primary_10_1002_wrna_1719 crossref_primary_10_1016_j_critrevonc_2025_104909 crossref_primary_10_1016_j_rbmo_2021_10_012 crossref_primary_10_1007_s12672_023_00620_7 crossref_primary_10_1038_s41598_022_14897_1 crossref_primary_10_1186_s12957_022_02617_y crossref_primary_10_1016_j_ijrobp_2023_05_029 crossref_primary_10_1186_s12929_021_00724_8 crossref_primary_10_3892_or_2023_8625 crossref_primary_10_1016_j_lfs_2021_120257 crossref_primary_10_3389_fonc_2022_780950 crossref_primary_10_1155_2021_2182761 crossref_primary_10_1111_jcmm_17200 crossref_primary_10_1007_s10495_022_01791_4 crossref_primary_10_1155_2022_1258480 crossref_primary_10_1038_s41416_024_02908_z crossref_primary_10_1007_s11255_023_03894_6 crossref_primary_10_1038_s41423_022_00905_x crossref_primary_10_1186_s13019_021_01540_9 crossref_primary_10_1186_s12920_023_01455_5 crossref_primary_10_3389_fgene_2022_891301 crossref_primary_10_1016_j_heliyon_2024_e38641 crossref_primary_10_1016_j_lfs_2024_122525 crossref_primary_10_1155_2022_1916787 crossref_primary_10_1002_anie_202501530 crossref_primary_10_1038_s41392_021_00507_5 crossref_primary_10_3390_genes13122281 crossref_primary_10_3390_pharmaceutics14020395 crossref_primary_10_1038_s41598_024_76997_4 crossref_primary_10_1016_j_cellimm_2024_104908 crossref_primary_10_1038_s41419_023_06068_5 crossref_primary_10_1038_s41420_021_00557_2 crossref_primary_10_1007_s10103_025_04595_5 crossref_primary_10_3390_pharmaceutics15071830 crossref_primary_10_1016_j_phrs_2021_105748 crossref_primary_10_1016_j_intimp_2020_106489 crossref_primary_10_3389_fgene_2022_823443 crossref_primary_10_1038_s41598_023_44700_8 crossref_primary_10_1111_cas_15059 crossref_primary_10_1186_s12964_024_01932_z crossref_primary_10_3389_fmed_2022_760722 crossref_primary_10_3389_fgene_2022_905051 crossref_primary_10_1038_s41598_023_36720_1 crossref_primary_10_1089_ars_2021_0192 crossref_primary_10_2147_JIR_S440425 crossref_primary_10_1016_j_canlet_2021_07_014 crossref_primary_10_2174_0109298673276128231031112655 crossref_primary_10_3389_fimmu_2021_710110 crossref_primary_10_3389_fgene_2021_789296 crossref_primary_10_3389_fonc_2024_1336734 crossref_primary_10_1002_anie_202010281 crossref_primary_10_3389_fimmu_2022_1062225 crossref_primary_10_3389_fgene_2021_792106 crossref_primary_10_3390_cancers16081491 crossref_primary_10_3389_fonc_2022_934076 crossref_primary_10_3389_fphys_2022_917323 crossref_primary_10_1097_MD_0000000000032793 crossref_primary_10_3389_fgene_2022_860727 crossref_primary_10_3389_fimmu_2022_1110602 crossref_primary_10_1038_s41598_022_26110_4 crossref_primary_10_3389_fgene_2021_781538 crossref_primary_10_1111_1440_1681_70056 crossref_primary_10_2147_CMAR_S325710 crossref_primary_10_1007_s11010_024_05062_5 crossref_primary_10_1155_2022_8346816 crossref_primary_10_3389_fimmu_2022_1042622 crossref_primary_10_1007_s00405_023_08316_y crossref_primary_10_1016_j_aquaculture_2021_736760 crossref_primary_10_3390_jpm13010069 crossref_primary_10_4103_jcrt_jcrt_126_22 crossref_primary_10_1038_s41598_022_13212_2 crossref_primary_10_3389_fimmu_2024_1381778 crossref_primary_10_1186_s13046_022_02267_8 crossref_primary_10_3389_fimmu_2020_574990 crossref_primary_10_1016_j_compbiomed_2023_107343 crossref_primary_10_1155_2022_1749111 crossref_primary_10_1016_j_ijbiomac_2023_124832 crossref_primary_10_1111_imm_13633 crossref_primary_10_12998_wjcc_v10_i24_8490 crossref_primary_10_1016_j_gene_2022_146243 crossref_primary_10_3390_ijms222011239 crossref_primary_10_1155_2022_6365485 crossref_primary_10_3390_biom12070895 crossref_primary_10_1002_mef2_70014 crossref_primary_10_1097_MD_0000000000043782 crossref_primary_10_1007_s00262_022_03148_x crossref_primary_10_4103_cjop_CJOP_D_22_00137 crossref_primary_10_1186_s12935_021_02384_y crossref_primary_10_1111_jcmm_17247 crossref_primary_10_1016_j_etap_2021_103686 crossref_primary_10_3390_biom14070874 crossref_primary_10_3389_fgene_2022_1026192 crossref_primary_10_1016_j_cej_2025_168410 crossref_primary_10_2147_IJGM_S337735 crossref_primary_10_1016_j_fct_2020_111867 crossref_primary_10_1038_s41598_022_22864_z crossref_primary_10_1016_j_pnpbp_2025_111325 crossref_primary_10_1155_2022_2371807 crossref_primary_10_1002_mco2_70250 crossref_primary_10_3390_jpm13010085 crossref_primary_10_1016_j_advms_2022_03_001 crossref_primary_10_1016_j_omtn_2024_102416 crossref_primary_10_1038_s41420_022_00915_8 crossref_primary_10_3389_fonc_2022_948169 crossref_primary_10_2147_JIR_S486878 crossref_primary_10_1002_cam4_5178 crossref_primary_10_1038_s41556_020_00582_w crossref_primary_10_1016_j_matt_2022_08_026 crossref_primary_10_3389_fcell_2022_779269 crossref_primary_10_3389_fonc_2024_1438306 crossref_primary_10_1155_jfbc_7630023 crossref_primary_10_1016_j_cellsig_2023_110952 crossref_primary_10_1111_cas_16180 crossref_primary_10_3389_fonc_2021_774279 crossref_primary_10_3389_fgene_2023_1087563 crossref_primary_10_1155_2022_2035808 crossref_primary_10_3389_fimmu_2023_1073561 crossref_primary_10_1002_cbin_11705 crossref_primary_10_3389_fonc_2022_986827 crossref_primary_10_3390_ph18030303 crossref_primary_10_1186_s12890_023_02456_x crossref_primary_10_1016_j_cyto_2022_156014 crossref_primary_10_1002_ctm2_492 crossref_primary_10_7717_peerj_14691 crossref_primary_10_1186_s12885_023_10850_1 crossref_primary_10_1155_2022_4627845 crossref_primary_10_1155_2022_9141117 crossref_primary_10_3389_fimmu_2022_925290 crossref_primary_10_1002_ar_24415 crossref_primary_10_1038_s41598_022_24879_y crossref_primary_10_1002_ijc_35035 crossref_primary_10_1038_s41420_020_00349_0 crossref_primary_10_3389_fmed_2022_822806 crossref_primary_10_1158_0008_5472_CAN_22_1002 crossref_primary_10_1097_MD_0000000000038173 crossref_primary_10_1016_j_tranon_2021_101233 crossref_primary_10_1111_1759_7714_15180 crossref_primary_10_3389_fcell_2022_805291 crossref_primary_10_1158_2159_8290_CD_20_0789 crossref_primary_10_1186_s12885_022_10097_2 crossref_primary_10_1051_vcm_2025006 crossref_primary_10_3389_fonc_2021_698811 crossref_primary_10_1111_jcmm_17277 crossref_primary_10_1002_advs_202304263 crossref_primary_10_1007_s13577_022_00791_5 crossref_primary_10_2147_IJGM_S367693 crossref_primary_10_3389_fnins_2022_922331 crossref_primary_10_3389_fonc_2023_1122789 crossref_primary_10_3389_fimmu_2025_1511453 crossref_primary_10_3389_fonc_2022_812655 crossref_primary_10_3389_fcell_2022_702224 crossref_primary_10_3389_fmolb_2021_781427 crossref_primary_10_1186_s12885_021_09046_2 crossref_primary_10_1016_j_phrs_2021_105447 crossref_primary_10_3389_fphar_2021_767187 crossref_primary_10_1111_jre_13035 crossref_primary_10_1155_2022_2680110 crossref_primary_10_3389_fmolb_2022_972087 crossref_primary_10_1097_MD_0000000000030304 crossref_primary_10_1016_j_biopha_2023_114792 crossref_primary_10_1016_j_tranon_2022_101524 crossref_primary_10_3389_fonc_2022_794034 crossref_primary_10_1007_s12672_022_00495_0 crossref_primary_10_1038_s41598_022_08619_w crossref_primary_10_1155_2023_7040113 crossref_primary_10_1007_s13402_023_00787_9 crossref_primary_10_3389_fgene_2021_780780 crossref_primary_10_1007_s12032_022_01945_z crossref_primary_10_15212_AMM_2025_0014 crossref_primary_10_3389_fimmu_2024_1322468 crossref_primary_10_1007_s10238_023_01108_y |
| Cites_doi | 10.1046/j.1432-1327.1998.2520169.x 10.1128/IAI.73.4.1907-1916.2005 10.1084/jem.20100050 10.7150/ijbs.23542 10.1038/ni.1960 10.1016/j.tibs.2016.10.004 10.2217/fmb.12.140 10.1016/S0966-842X(00)01937-5 10.1007/s10549-009-0600-1 10.1038/s41591-018-0082-y 10.1038/nature18629 10.1007/s10038-006-0004-6 10.1016/S0092-8674(00)80943-5 10.1111/imr.12534 10.1016/j.immuni.2010.02.012 10.1007/s00018-017-2477-1 10.1016/j.canlet.2019.02.014 10.1007/s13238-013-0001-4 10.15430/JCP.2017.22.2.62 10.1186/1476-4598-11-87 10.1126/science.aau2818 10.1016/j.lfs.2018.06.015 10.1016/S0966-842X(00)01936-3 10.1038/nature10558 10.1038/s41388-018-0339-4 10.1126/science.aar7607 10.1016/j.celrep.2018.02.067 10.1073/pnas.1607769113 10.1016/j.bbcan.2019.05.001 10.1158/1541-7786.MCR-18-0910 10.1016/S0014-5793(01)02304-3 10.1038/s41598-018-21998-3 10.1073/pnas.96.5.2396 10.1016/j.jcmgh.2016.03.006 10.1083/jcb.149.3.613 10.1016/j.bbrc.2017.11.156 10.1016/j.canlet.2011.10.001 10.1007/s003350010138 10.1128/JVI.01275-12 10.1038/nature18590 10.1038/nature12940 10.1266/ggs.85.75 10.1111/1751-2980.12576 10.1002/jcp.25930 10.1074/mcp.M900528-MCP200 10.1038/sj.onc.1211021 10.1038/s41422-018-0090-y 10.1016/j.ebiom.2019.02.012 10.1111/j.1349-7006.2001.tb01076.x 10.1097/PPO.0000000000000004 10.1111/imr.12287 10.1158/1078-0432.CCR-18-1478 10.1155/2018/2864120 10.3727/096504016X14813859905646 10.1038/cr.2016.100 10.1038/s41388-018-0613-5 10.1038/358167a0 10.1016/j.jmb.2018.07.002 10.1084/jem.20050977 10.1073/pnas.1601700113 10.1002/1097-0215(20001115)88:4<535::AID-IJC4>3.0.CO;2-V 10.1007/s11033-013-2581-8 10.1073/pnas.1809548115 10.1038/nchembio.2229 10.1007/s10495-019-01515-1 10.1016/j.phymed.2018.09.223 10.1038/s41401-019-0222-z 10.1007/s11427-017-9142-2 10.1186/s13148-018-0479-y 10.1038/labinvest.2013.126 10.3389/fimmu.2013.00370 10.1038/cdd.2014.117 10.1038/nrmicro2070 10.1016/j.cell.2014.04.007 10.1073/pnas.93.18.9833 10.1002/cam4.2103 10.1016/j.semcancer.2014.05.002 10.1016/j.celrep.2019.05.065 10.3727/096504018X15462920753012 10.1038/cdd.2017.24 10.1016/j.it.2011.02.002 10.1111/j.1349-7006.2006.00351.x 10.1038/sj.cdd.4402059 10.1038/gt.2009.126 10.1073/pnas.1016814108 10.1084/jem.20150237 10.1111/cbdd.13514 10.1016/j.intimp.2019.105713 10.1007/s10495-018-1499-y 10.1016/j.tranon.2019.04.010 10.1038/srep16222 10.1038/nature22393 10.1146/annurev-biochem-061809-121639 10.1038/nature13683 10.1038/ncomms14128 10.1080/00313020701716250 10.1038/s41419-019-1441-4 10.1126/science.aaf7532 10.1016/j.smim.2013.10.018 10.1371/journal.pone.0166422 10.1038/s41598-018-20422-0 10.1371/journal.ppat.0030161 10.1016/j.bbrc.2008.03.026 10.1371/journal.pone.0090099 10.1038/ncomms4209 10.1002/gcc.20636 10.15252/emmm.201404084 10.1038/s41418-017-0012-4 10.1073/pnas.1402911111 10.4049/jimmunol.1402098 10.1038/nature15541 10.1158/0008-5472.CAN-18-0730 10.1111/j.1462-5822.2006.00751.x 10.1002/ijc.28891 10.1038/cddis.2014.532 10.1038/nature15514 10.18632/oncotarget.12384 10.1128/iai.65.12.5165-5170.1997 10.1038/s41568-019-0123-y 10.18632/oncotarget.9154 10.1158/1538-7445.AM2015-3424 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2019 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2019 – notice: 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DOI | 10.1038/s41419-019-1883-8 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2041-4889 |
| EndPage | 13 |
| ExternalDocumentID | PMC6733901 31501419 10_1038_s41419_019_1883_8 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GroupedDBID | --- 0R~ 3V. 53G 5VS 70F 7X7 88A 88I 8FE 8FH 8FI 8FJ AAJSJ ABUWG ACGFS ACSMW ADBBV AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO E3Z EBLON EBS EJD EMOBN FRP FYUFA GNUQQ GROUPED_DOAJ HCIFZ HMCUK HYE HZ~ KQ8 LK8 M0L M2P M48 M7P M~E NAO O5R O5S O9- OK1 PIMPY PQQKQ PROAC RNT RPM SNYQT TR2 UKHRP W2D AASML AAYXX AFFHD CITATION PHGZM PHGZT PQGLB CGR CUY CVF ECM EIF NPM 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c536t-b15d4f22d9b09b2dd65c1ba5fa401be039754bd237a9ae09978efa072ac2b2e3 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 659 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000494969700009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2041-4889 |
| IngestDate | Tue Nov 04 01:55:58 EST 2025 Sun Aug 24 04:21:12 EDT 2025 Tue Oct 07 06:47:49 EDT 2025 Mon Jul 21 05:49:51 EDT 2025 Tue Nov 18 21:36:31 EST 2025 Sat Nov 29 05:57:06 EST 2025 Fri Feb 21 02:37:00 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Language | English |
| License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c536t-b15d4f22d9b09b2dd65c1ba5fa401be039754bd237a9ae09978efa072ac2b2e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Literature Review-3 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0001-7717-8411 |
| OpenAccessLink | https://www.proquest.com/docview/2304873339?pq-origsite=%requestingapplication% |
| PMID | 31501419 |
| PQID | 2304873339 |
| PQPubID | 2041963 |
| PageCount | 13 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733901 proquest_miscellaneous_2288003533 proquest_journals_2304873339 pubmed_primary_31501419 crossref_citationtrail_10_1038_s41419_019_1883_8 crossref_primary_10_1038_s41419_019_1883_8 springer_journals_10_1038_s41419_019_1883_8 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-09-09 |
| PublicationDateYYYYMMDD | 2019-09-09 |
| PublicationDate_xml | – month: 09 year: 2019 text: 2019-09-09 day: 09 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Cell death & disease |
| PublicationTitleAbbrev | Cell Death Dis |
| PublicationTitleAlternate | Cell Death Dis |
| PublicationYear | 2019 |
| Publisher | Nature Publishing Group UK Springer Nature B.V |
| Publisher_xml | – name: Nature Publishing Group UK – name: Springer Nature B.V |
| References | Shi (CR32) 2014; 514 Falcon (CR58) 2018; 2018 Wei, Zhu, Zhu, Zhao, Li (CR52) 2019; 27 Wang (CR35) 1998; 92 Wang (CR123) 2019; 450 Doitsh (CR109) 2014; 505 Shi, Gao, Shao (CR21) 2017; 42 Li, Wang, Pappan, Galliher-Beckley, Shi (CR100) 2012; 11 Aglietti (CR41) 2016; 113 He (CR67) 2017; 74 Thi, Hong (CR7) 2017; 22 Wang (CR85) 2018; 19 Song, Du, Feng, Wu, Yan (CR110) 2013; 42 Kim (CR62) 2008; 370 Sarhan (CR43) 2018; 115 Wei (CR51) 2014; 94 Xi (CR92) 2019; 74 Lu (CR93) 2018; 24 Orning (CR45) 2018; 362 Timmer, Salvesen (CR38) 2007; 14 Chen (CR119) 2019; 94 Yu (CR78) 2019; 40 Hergueta-Redondo (CR59) 2014; 9 Yue (CR115) 2019; 56 Zhao, Zhou, Ren, Yang, Zhang (CR97) 2017; 32 Kayagaki (CR36) 2011; 479 Johnson (CR118) 2018; 24 Fulda (CR130) 2015; 31 Man (CR28) 2014; 111 Watabe (CR75) 2001; 92 Martirosyan, Gorvel (CR19) 2013; 8 Nadatani (CR103) 2016; 2 Fink, Cookson (CR1) 2005; 73 Wang (CR89) 2018; 495 Ruhl (CR44) 2018; 362 Wang, Sun (CR27) 2015; 31 Chu (CR56) 2016; 7 Zhou (CR128) 2018; 28 Dupaul-Chicoine (CR47) 2010; 32 Boise, Collins (CR16) 2001; 9 Jiao (CR126) 2018; 2018 Van Opdenbosch (CR25) 2014; 5 Hoseini (CR95) 2018; 233 Fink, Cookson (CR4) 2006; 8 Cookson, Brennan (CR11) 2001; 9 Shi (CR63) 2019; 26 Croes (CR131) 2018; 10 Jorgensen, Miao (CR29) 2015; 265 Chen (CR5) 2016; 26 Melotti (CR111) 2014; 6 Thompson, Weigel (CR60) 1998; 252 Bergsbaken, Cookson (CR3) 2007; 3 Chen (CR113) 2019; 24 Kayagaki (CR33) 2015; 526 Dihlmann (CR66) 2014; 135 Feng, Fox, Man (CR90) 2018; 430 Grottke, Mantwill, Dietel, Schadendorf, Lage (CR76) 2000; 88 Chen, Qi, Wu (CR55) 2018; 22 Bergsbaken, Fink, Cookson (CR6) 2009; 7 Ibrahim (CR74) 2019; 8 Carl-Mcgrath, Schneider-Stock, Ebert, Roecken (CR84) 2008; 40 Kambara (CR22) 2018; 22 Lamkanfi, Dixit (CR24) 2014; 157 Kang (CR34) 2000; 149 Ma (CR53) 2016; 7 Saeki, Kuwahara, Sasaki, Satoh, Shiroishi (CR86) 2000; 11 Crawford, Wells (CR39) 2011; 80 Zychlinsky, Prevost, Sansonetti (CR13) 1992; 358 Agard, Maltby, Wells (CR37) 2010; 9 Pizato (CR114) 2018; 8 Man, Karki, Kanneganti (CR31) 2017; 277 Cui (CR106) 2019; 17 Zaki, Lamkanfi, Kanneganti (CR50) 2011; 32 Gao (CR91) 2018; 40 Nagarajan, Soundarapandian, Thorne, Li, Li (CR10) 2019; 12 Monack, Raupach, Hromockyj, Falkow (CR12) 1996; 93 Shi (CR17) 2015; 526 Zhou, Fang (CR8) 2019; 1872 Komiyama (CR83) 2010; 85 Wang (CR20) 2017; 547 Gao, Yang, Liu, Wang, Shao (CR54) 2016; 113 Chien, Dix (CR108) 2012; 86 Tabraue (CR125) 2019; 104 Dunn, Ellis, Fujita (CR101) 2012; 314 Hilbi, Chen, Thirumalai, Zychlinsky (CR14) 1997; 65 Chen (CR69) 2015; 6 Qiu, Liu, Xing (CR81) 2017; 24 Burgener (CR46) 2019; 27 Wang (CR129) 2018; 14 Fujikane (CR61) 2010; 122 Flood (CR70) 2019; 38 Miguchi (CR73) 2016; 11 Akino (CR87) 2007; 98 Karki, Kanneganti (CR26) 2019; 19 Zhang (CR121) 2019; 24 Wang (CR57) 2013; 40 Orita (CR72) 2015; 75 Okondo (CR117) 2017; 13 Elion (CR116) 2018; 78 So (CR96) 2018; 37 Williams (CR68) 2015; 194 Wei, Sun, Li, Liu, Jiao (CR9) 2018; 45 Kim (CR88) 2008; 27 Liu (CR40) 2016; 535 Masuda (CR64) 2006; 51 Hu (CR48) 2010; 107 Colunga, Laing, Aurelian (CR127) 2010; 17 Joosten, Netea, Dinarello (CR30) 2013; 25 Ma, Chen, Lin, Hu (CR71) 2018; 40 Kolb, Liu, Janowski, Sutterwala, Zhang (CR102) 2014; 5 Saeki (CR82) 2009; 48 Lee (CR79) 2018; 8 Hu (CR65) 2016; 354 Miao (CR107) 2010; 11 Derangere (CR124) 2014; 21 Galluzzi (CR23) 2018; 25 Yu (CR120) 2019; 10 Freeman (CR80) 2017; 214 Mariathasan, Weiss, Dixit, Monack (CR2) 2005; 202 Wu (CR104) 2019; 41 Yu, He (CR122) 2017; 60 Jiang (CR105) 2017; 25 Rogers (CR42) 2017; 8 Zhang, Li, Liu (CR94) 2018; 207 Drexler, Yazdi (CR99) 2013; 19 Janowski, Kolb, Zhang, Sutterwala (CR98) 2013; 4 Lage, Helmbach, Grottke, Dietel, Schadendorf (CR77) 2001; 494 Allen (CR49) 2010; 207 Hersh (CR15) 1999; 96 Draganov (CR112) 2015; 5 Ding (CR18) 2016; 535 B Zhou (1883_CR128) 2018; 28 L Croes (1883_CR131) 2018; 10 JC Timmer (1883_CR38) 2007; 14 YF Chen (1883_CR55) 2018; 22 A Martirosyan (1883_CR19) 2013; 8 Z Zhao (1883_CR97) 2017; 32 ED Crawford (1883_CR39) 2011; 80 J Shi (1883_CR32) 2014; 514 X Yu (1883_CR122) 2017; 60 SL Fink (1883_CR4) 2006; 8 M Lamkanfi (1883_CR24) 2014; 157 N Saeki (1883_CR82) 2009; 48 K Watabe (1883_CR75) 2001; 92 X Ma (1883_CR53) 2016; 7 Y Wang (1883_CR89) 2018; 495 N Kayagaki (1883_CR33) 2015; 526 NJ Agard (1883_CR37) 2010; 9 N Saeki (1883_CR86) 2000; 11 X Liu (1883_CR40) 2016; 535 K Nagarajan (1883_CR10) 2019; 12 Z Jiang (1883_CR105) 2017; 25 SL Fink (1883_CR1) 2005; 73 P Yu (1883_CR78) 2019; 40 SK Drexler (1883_CR99) 2013; 19 T Fujikane (1883_CR61) 2010; 122 C Chen (1883_CR69) 2015; 6 B Hu (1883_CR65) 2016; 354 DL Elion (1883_CR116) 2018; 78 J Ding (1883_CR18) 2016; 535 R Kolb (1883_CR102) 2014; 5 G Xi (1883_CR92) 2019; 74 Y Nadatani (1883_CR103) 2016; 2 H Thi (1883_CR7) 2017; 22 SM Man (1883_CR28) 2014; 111 L He (1883_CR67) 2017; 74 MC Okondo (1883_CR117) 2017; 13 G Doitsh (1883_CR109) 2014; 505 H Kambara (1883_CR22) 2018; 22 CB Zhou (1883_CR8) 2019; 1872 Q Chu (1883_CR56) 2016; 7 N Kayagaki (1883_CR36) 2011; 479 AM Janowski (1883_CR98) 2013; 4 L Freeman (1883_CR80) 2017; 214 E Yue (1883_CR115) 2019; 56 W Gao (1883_CR54) 2016; 113 H Zhang (1883_CR94) 2018; 207 J Song (1883_CR110) 2013; 42 C Rogers (1883_CR42) 2017; 8 A Melotti (1883_CR111) 2014; 6 S Wang (1883_CR35) 1998; 92 H Hilbi (1883_CR14) 1997; 65 H Lu (1883_CR93) 2018; 24 DM Monack (1883_CR12) 1996; 93 K Akino (1883_CR87) 2007; 98 D Draganov (1883_CR112) 2015; 5 N Van Opdenbosch (1883_CR25) 2014; 5 Y Wang (1883_CR27) 2015; 31 Q Wei (1883_CR52) 2019; 27 DA Thompson (1883_CR60) 1998; 252 J Shi (1883_CR17) 2015; 526 EA Miao (1883_CR107) 2010; 11 J Cui (1883_CR106) 2019; 17 H Chien (1883_CR108) 2012; 86 S Qiu (1883_CR81) 2017; 24 J Dupaul-Chicoine (1883_CR47) 2010; 32 MH Zaki (1883_CR50) 2011; 32 BL Lee (1883_CR79) 2018; 8 LA Joosten (1883_CR30) 2013; 25 T Falcon (1883_CR58) 2018; 2018 C Grottke (1883_CR76) 2000; 88 S Feng (1883_CR90) 2018; 430 TM Williams (1883_CR68) 2015; 194 L Wang (1883_CR123) 2019; 450 CC Zhang (1883_CR121) 2019; 24 S Dihlmann (1883_CR66) 2014; 135 Y Ma (1883_CR71) 2018; 40 RA Aglietti (1883_CR41) 2016; 113 J Sarhan (1883_CR43) 2018; 115 R Karki (1883_CR26) 2019; 19 H Lage (1883_CR77) 2001; 494 WJ Wang (1883_CR85) 2018; 19 C Tabraue (1883_CR125) 2019; 104 CJ Wang (1883_CR57) 2013; 40 Y Masuda (1883_CR64) 2006; 51 BT Cookson (1883_CR11) 2001; 9 LH Boise (1883_CR16) 2001; 9 H Orita (1883_CR72) 2015; 75 SM Man (1883_CR31) 2017; 277 F Wang (1883_CR129) 2018; 14 M Hergueta-Redondo (1883_CR59) 2014; 9 J Gao (1883_CR91) 2018; 40 M Wu (1883_CR104) 2019; 41 J Yu (1883_CR120) 2019; 10 L Chen (1883_CR113) 2019; 24 J Shi (1883_CR21) 2017; 42 S Carl-Mcgrath (1883_CR84) 2008; 40 Q Wei (1883_CR51) 2014; 94 J Ibrahim (1883_CR74) 2019; 8 Z Wei (1883_CR9) 2018; 45 Z Hoseini (1883_CR95) 2018; 233 B Hu (1883_CR48) 2010; 107 MS Kim (1883_CR62) 2008; 370 H Komiyama (1883_CR83) 2010; 85 B Flood (1883_CR70) 2019; 38 D Hersh (1883_CR15) 1999; 96 SS Burgener (1883_CR46) 2019; 27 IC Allen (1883_CR49) 2010; 207 AG Colunga (1883_CR127) 2010; 17 X Chen (1883_CR5) 2016; 26 L Galluzzi (1883_CR23) 2018; 25 S Ruhl (1883_CR44) 2018; 362 P Orning (1883_CR45) 2018; 362 MS Kim (1883_CR88) 2008; 27 T Bergsbaken (1883_CR3) 2007; 3 V Derangere (1883_CR124) 2014; 21 S Fulda (1883_CR130) 2015; 31 T Bergsbaken (1883_CR6) 2009; 7 Y Jiao (1883_CR126) 2018; 2018 N Pizato (1883_CR114) 2018; 8 Y Shi (1883_CR63) 2019; 26 Y Wang (1883_CR20) 2017; 547 D So (1883_CR96) 2018; 37 L Chen (1883_CR119) 2019; 94 SJ Kang (1883_CR34) 2000; 149 DC Johnson (1883_CR118) 2018; 24 M Miguchi (1883_CR73) 2016; 11 I Jorgensen (1883_CR29) 2015; 265 JH Dunn (1883_CR101) 2012; 314 S Mariathasan (1883_CR2) 2005; 202 Y Li (1883_CR100) 2012; 11 A Zychlinsky (1883_CR13) 1992; 358 |
| References_xml | – volume: 252 start-page: 169 year: 1998 ident: CR60 article-title: Characterization of a gene that is inversely correlated with estrogen receptor expression (ICERE-1) in breast carcinomas publication-title: Eur. J. Biochem doi: 10.1046/j.1432-1327.1998.2520169.x – volume: 73 start-page: 1907 year: 2005 end-page: 1916 ident: CR1 article-title: Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells publication-title: Infect. Immun. doi: 10.1128/IAI.73.4.1907-1916.2005 – volume: 207 start-page: 1045 year: 2010 end-page: 1056 ident: CR49 article-title: The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer publication-title: J. Exp. Med. doi: 10.1084/jem.20100050 – volume: 40 start-page: 1971 year: 2018 end-page: 1984 ident: CR91 article-title: Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in nonsmall cell lung cancer publication-title: Oncol. Rep. – volume: 14 start-page: 406 year: 2018 end-page: 417 ident: CR129 article-title: Simvastatin suppresses proliferation and migration in non-small cell lung cancer via pyroptosis publication-title: Int. J. Biol. Sci. doi: 10.7150/ijbs.23542 – volume: 11 start-page: 1136 year: 2010 end-page: 1142 ident: CR107 article-title: Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria publication-title: Nat. Immunol doi: 10.1038/ni.1960 – volume: 42 start-page: 245 year: 2017 end-page: 254 ident: CR21 article-title: Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death publication-title: Trends Biochem. Sci. doi: 10.1016/j.tibs.2016.10.004 – volume: 8 start-page: 147 year: 2013 end-page: 154 ident: CR19 article-title: Brucella evasion of adaptive immunity publication-title: Future Microbiol doi: 10.2217/fmb.12.140 – volume: 9 start-page: 64 year: 2001 end-page: 67 ident: CR16 article-title: Salmonella-induced cell death: apoptosis, necrosis or programmed cell death? publication-title: Trends Microbio.l doi: 10.1016/S0966-842X(00)01937-5 – volume: 122 start-page: 699 year: 2010 end-page: 710 ident: CR61 article-title: Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-009-0600-1 – volume: 24 start-page: 1151 year: 2018 ident: CR118 article-title: DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia publication-title: Nat. Med. doi: 10.1038/s41591-018-0082-y – volume: 535 start-page: 153 year: 2016 end-page: 158 ident: CR40 article-title: Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores publication-title: Nature doi: 10.1038/nature18629 – volume: 51 start-page: 652 year: 2006 ident: CR64 article-title: The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage publication-title: J. Hum. Genet. doi: 10.1007/s10038-006-0004-6 – volume: 92 start-page: 501 year: 1998 end-page: 509 ident: CR35 article-title: Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE publication-title: Cell doi: 10.1016/S0092-8674(00)80943-5 – volume: 277 start-page: 61 year: 2017 end-page: 75 ident: CR31 article-title: Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases publication-title: Immunol. Rev. doi: 10.1111/imr.12534 – volume: 32 start-page: 367 year: 2010 end-page: 378 ident: CR47 article-title: Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases publication-title: Immunity doi: 10.1016/j.immuni.2010.02.012 – volume: 74 start-page: 2395 year: 2017 end-page: 2411 ident: CR67 article-title: Nucleic acid sensing pattern recognition receptors in the development of colorectal cancer and colitis publication-title: Cell. Mol. Life Sci. doi: 10.1007/s00018-017-2477-1 – volume: 450 start-page: 22 year: 2019 end-page: 31 ident: CR123 article-title: Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497/PELP1 axis publication-title: Cancer Lett doi: 10.1016/j.canlet.2019.02.014 – volume: 5 start-page: 12 year: 2014 end-page: 20 ident: CR102 article-title: Inflammasomes in cancer: a double-edged sword publication-title: Protein Cell doi: 10.1007/s13238-013-0001-4 – volume: 22 start-page: 62 year: 2017 ident: CR7 article-title: Inflammasome as a therapeutic target for cancer prevention and treatment publication-title: J. Cancer Prev. doi: 10.15430/JCP.2017.22.2.62 – volume: 11 year: 2012 ident: CR100 article-title: IL-1beta promotes stemness and invasiveness of colon cancer cells through Zeb1 activation publication-title: Mol. Cancer doi: 10.1186/1476-4598-11-87 – volume: 362 start-page: 1064 year: 2018 end-page: 1069 ident: CR45 article-title: Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death publication-title: Science doi: 10.1126/science.aau2818 – volume: 207 start-page: 296 year: 2018 end-page: 303 ident: CR94 article-title: FcgammaRI (CD64) contributes to the severity of immune inflammation through regulating NF-kappaB/NLRP3 inflammasome pathway publication-title: Life Sci doi: 10.1016/j.lfs.2018.06.015 – volume: 9 start-page: 113 year: 2001 end-page: 114 ident: CR11 article-title: Pro-inflammatory programmed cell death publication-title: Trends Microbiol doi: 10.1016/S0966-842X(00)01936-3 – volume: 479 start-page: 117 year: 2011 ident: CR36 article-title: Non-canonical inflammasome activation targets caspase-11 publication-title: Nature doi: 10.1038/nature10558 – volume: 37 start-page: 5191 year: 2018 end-page: 5204 ident: CR96 article-title: Cervical cancer is addicted to SIRT1 disarming the AIM2 antiviral defense publication-title: Oncogene doi: 10.1038/s41388-018-0339-4 – volume: 362 start-page: 956 year: 2018 end-page: 960 ident: CR44 article-title: ESCRT-dependent membrane repair negatively regulates pyroptosis downstream of GSDMD activation publication-title: Science doi: 10.1126/science.aar7607 – volume: 22 start-page: 2924 year: 2018 end-page: 2936 ident: CR22 article-title: Gasdermin D exerts anti-inflammatory effects by promoting neutrophil death publication-title: Cell Rep. doi: 10.1016/j.celrep.2018.02.067 – volume: 45 start-page: 1117 year: 2018 end-page: 1121 ident: CR9 article-title: Advances of research in cancer-associated inflammation and tumor microenvironments publication-title: Chin. J. Clin. Oncol. – volume: 113 start-page: 7858 year: 2016 end-page: 7863 ident: CR41 article-title: GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1607769113 – volume: 1872 start-page: 1 year: 2019 end-page: 10 ident: CR8 article-title: The role of pyroptosis in gastrointestinal cancer and immune responses to intestinal microbial infection publication-title: Biochim Biophys. Acta Rev. Cancer doi: 10.1016/j.bbcan.2019.05.001 – volume: 17 start-page: 1316 year: 2019 end-page: 1325 ident: CR106 article-title: MST1 suppresses pancreatic cancer progression via ROS-induced pyroptosis publication-title: Mol. Cancer. Res doi: 10.1158/1541-7786.MCR-18-0910 – volume: 494 start-page: 54 year: 2001 end-page: 59 ident: CR77 article-title: DFNA5 (ICERE-1) contributes to acquired etoposide resistance in melanoma cells publication-title: FEBS Lett. doi: 10.1016/S0014-5793(01)02304-3 – volume: 8 year: 2018 ident: CR79 article-title: ASC- and caspase-8-dependent apoptotic pathway diverges from the NLRC4 inflammasome in macrophages publication-title: Sci. Rep. doi: 10.1038/s41598-018-21998-3 – volume: 96 start-page: 2396 year: 1999 end-page: 2401 ident: CR15 article-title: The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.96.5.2396 – volume: 2 start-page: 439 year: 2016 end-page: 453 ident: CR103 article-title: NOD-like receptor protein 3 inflammasome priming and activation in Barrett’s epithelial cells publication-title: Cell Mol. Gastroenterol. Hepatol. doi: 10.1016/j.jcmgh.2016.03.006 – volume: 149 start-page: 613 year: 2000 end-page: 622 ident: CR34 article-title: Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions publication-title: J. Cell Biol. doi: 10.1083/jcb.149.3.613 – volume: 75 start-page: 3424 year: 2015 ident: CR72 article-title: The efficacy of Gasdermin gene family for tumor marker in colorectal cancer publication-title: Cancer Res. – volume: 495 start-page: 1418 year: 2018 end-page: 1425 ident: CR89 article-title: GSDME mediates caspase-3-dependent pyroptosis in gastric cancer publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2017.11.156 – volume: 314 start-page: 24 year: 2012 end-page: 33 ident: CR101 article-title: Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma publication-title: Cancer Lett doi: 10.1016/j.canlet.2011.10.001 – volume: 11 start-page: 718 year: 2000 end-page: 724 ident: CR86 article-title: Gasdermin (Gsdm) localizing to mouse Chromosome 11 is predominantly expressed in upper gastrointestinal tract but significantly suppressed in human gastric cancer cells publication-title: Mamm. Genome doi: 10.1007/s003350010138 – volume: 86 start-page: 10961 year: 2012 end-page: 10978 ident: CR108 article-title: Evidence for multiple cell death pathways during development of experimental cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression: apoptosis, necroptosis, and pyroptosis publication-title: J. Virol doi: 10.1128/JVI.01275-12 – volume: 535 start-page: 111 year: 2016 ident: CR18 article-title: Pore-forming activity and structural autoinhibition of the gasdermin family publication-title: Nature doi: 10.1038/nature18590 – volume: 2018 start-page: 5912194 year: 2018 ident: CR126 article-title: Pyroptosis of MCF7 cells induced by the secreted factors of hUCMSCs publication-title: Stem Cells Int. – volume: 505 start-page: 509 year: 2014 end-page: 514 ident: CR109 article-title: Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection publication-title: Nature doi: 10.1038/nature12940 – volume: 85 start-page: 75 year: 2010 end-page: 83 ident: CR83 article-title: Alu-derived cis-element regulates tumorigenesis-dependent gastric expression of GASDERMIN B (GSDMB) publication-title: Genes Genet. Syst. doi: 10.1266/ggs.85.75 – volume: 19 start-page: 74 year: 2018 end-page: 83 ident: CR85 article-title: Downregulation of gasdermin D promotes gastric cancer proliferation by regulating cell cycle-related proteins publication-title: J. Dig. Dis. doi: 10.1111/1751-2980.12576 – volume: 233 start-page: 2116 year: 2018 end-page: 2132 ident: CR95 article-title: NLRP3 inflammasome: Its regulation and involvement in atherosclerosis publication-title: J. Cell Physiol doi: 10.1002/jcp.25930 – volume: 104 start-page: 913 year: 2019 end-page: 923 ident: CR125 article-title: LXR signaling regulates macrophage survival and inflammation in response to ionizing radiation publication-title: Int – volume: 9 start-page: 880 year: 2010 end-page: 893 ident: CR37 article-title: Inflammatory stimuli regulate caspase substrate profiles publication-title: Mol. Cell Proteomics doi: 10.1074/mcp.M900528-MCP200 – volume: 27 start-page: 3624 year: 2008 ident: CR88 article-title: Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma publication-title: Oncogene doi: 10.1038/sj.onc.1211021 – volume: 28 start-page: 1171 year: 2018 end-page: 1185 ident: CR128 article-title: Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis publication-title: Cell Res. doi: 10.1038/s41422-018-0090-y – volume: 41 start-page: 244 year: 2019 end-page: 255 ident: CR104 article-title: A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma publication-title: Ebiomedicine doi: 10.1016/j.ebiom.2019.02.012 – volume: 92 start-page: 140 year: 2001 end-page: 151 ident: CR75 article-title: Structure, expression and chromosome mapping of MLZE, a novel gene which is preferentially expressed in metastatic melanoma cells publication-title: Jpn J. Cancer Res. doi: 10.1111/j.1349-7006.2001.tb01076.x – volume: 19 start-page: 468 year: 2013 end-page: 472 ident: CR99 article-title: Complex roles of inflammasomes in carcinogenesis publication-title: Cancer J. doi: 10.1097/PPO.0000000000000004 – volume: 265 start-page: 130 year: 2015 end-page: 142 ident: CR29 article-title: Pyroptotic cell death defends against intracellular pathogens publication-title: Immunol. Rev. doi: 10.1111/imr.12287 – volume: 26 start-page: 146 year: 2019 end-page: 151 ident: CR63 article-title: GSDME influences sensitivity of breast cancer MCF-7 cells to paclitaxel by regulating cell pyroptosis publication-title: Chin. J. Cancer Biother – volume: 24 start-page: 6066 year: 2018 end-page: 6077 ident: CR93 article-title: Molecular targeted therapies elicit concurrent apoptotic and GSDME-dependent pyroptotic tumor cell death publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-18-1478 – volume: 31 start-page: 721727 year: 2015 ident: CR27 article-title: Advances in inflammasome and inflammasome-related diseases publication-title: Chin. J. Immunol. – volume: 2018 start-page: 2864120 year: 2018 ident: CR58 article-title: Analysis of the Cancer Genome Atlas Data reveals novel putative ncRNAs targets in hepatocellular carcinoma publication-title: Biomed. Res. Int. doi: 10.1155/2018/2864120 – volume: 25 start-page: 1009 year: 2017 end-page: 1019 ident: CR105 article-title: miRNA-214 inhibits cellular proliferation and migration in glioma cells targeting caspase 1 involved in pyroptosis publication-title: Oncol. Res. doi: 10.3727/096504016X14813859905646 – volume: 32 start-page: 358 year: 2017 end-page: 360 ident: CR97 article-title: Correlation between IL-1β, IL-6, IL-17 expression, HPV infection and cervical cancer publication-title: Practical J. Cancer – volume: 26 start-page: 1007 year: 2016 ident: CR5 article-title: Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis publication-title: Cell Res. doi: 10.1038/cr.2016.100 – volume: 22 start-page: 8186 year: 2018 end-page: 8196 ident: CR55 article-title: Euxanthone exhibits anti-proliferative and anti-invasive activities in hepatocellular carcinoma by inducing pyroptosis: preliminary results publication-title: Eur. Rev. Med Pharm. Sci. – volume: 38 start-page: 2658 year: 2019 end-page: 2674 ident: CR70 article-title: Caspase-11 regulates the tumour suppressor function of STAT1 in a murine model of colitis-associated carcinogenesis publication-title: Oncogene doi: 10.1038/s41388-018-0613-5 – volume: 358 start-page: 167 year: 1992 end-page: 169 ident: CR13 article-title: Shigella flexneri induces apoptosis in infected macrophages publication-title: Nature doi: 10.1038/358167a0 – volume: 430 start-page: 3068 year: 2018 end-page: 3080 ident: CR90 article-title: Mechanisms of Gasdermin Family Members in Inflammasome Signaling and Cell Death publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2018.07.002 – volume: 202 start-page: 1043 year: 2005 end-page: 1049 ident: CR2 article-title: Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis publication-title: J. Exp. Med. doi: 10.1084/jem.20050977 – volume: 113 start-page: E4857 year: 2016 end-page: E4866 ident: CR54 article-title: Site-specific phosphorylation and microtubule dynamics control Pyrin inflammasome activation publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1601700113 – volume: 88 start-page: 535 year: 2000 end-page: 546 ident: CR76 article-title: Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs publication-title: Int. J. Cancer doi: 10.1002/1097-0215(20001115)88:4<535::AID-IJC4>3.0.CO;2-V – volume: 40 start-page: 6525 year: 2013 end-page: 6531 ident: CR57 article-title: The expression and regulation of DFNA5 in human hepatocellular carcinoma DFNA5 in hepatocellular carcinoma publication-title: Mol. Biol. Rep doi: 10.1007/s11033-013-2581-8 – volume: 115 start-page: E10888 year: 2018 end-page: E10897 ident: CR43 article-title: Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1809548115 – volume: 13 start-page: 46 year: 2017 ident: CR117 article-title: DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis publication-title: Nat. Chem. Biol doi: 10.1038/nchembio.2229 – volume: 24 start-page: 312 year: 2019 end-page: 325 ident: CR121 article-title: Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation publication-title: Apoptosis doi: 10.1007/s10495-019-01515-1 – volume: 56 start-page: 286 year: 2019 end-page: 294 ident: CR115 article-title: Anthocyanin is involved in the activation of pyroptosis in oral squamous cell carcinoma publication-title: Phytomedicine doi: 10.1016/j.phymed.2018.09.223 – volume: 7 start-page: 36185 year: 2016 end-page: 36197 ident: CR53 article-title: Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway publication-title: Oncotarget – volume: 40 start-page: 1237 year: 2019 end-page: 1244 ident: CR78 article-title: Eukaryotic elongation factor-2 kinase regulates the cross-talk between autophagy and pyroptosis in doxorubicin-treated human melanoma cells in vitro publication-title: Acta Pharmacol. Sin. doi: 10.1038/s41401-019-0222-z – volume: 60 start-page: 1291 year: 2017 end-page: 1294 ident: CR122 article-title: GSDME as an executioner of chemotherapy-induced cell death publication-title: Sci. China Life. Sci. doi: 10.1007/s11427-017-9142-2 – volume: 19 start-page: 197 year: 2019 ident: CR26 article-title: Diverging inflammasome signals in tumorigenesis and potential targeting publication-title: Nat. Rev. Cancer – volume: 10 year: 2018 ident: CR131 article-title: Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer publication-title: Clin. Epigenetics doi: 10.1186/s13148-018-0479-y – volume: 94 start-page: 52 year: 2014 end-page: 62 ident: CR51 article-title: Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression publication-title: Lab Invest. doi: 10.1038/labinvest.2013.126 – volume: 4 start-page: 370 year: 2013 ident: CR98 article-title: Beneficial and detrimental roles of NLRs in carcinogenesis publication-title: Front. Immunol doi: 10.3389/fimmu.2013.00370 – volume: 21 start-page: 1914 year: 2014 end-page: 1924 ident: CR124 article-title: Liver X receptor beta activation induces pyroptosis of human and murine colon cancer cells publication-title: Cell Death Differ. doi: 10.1038/cdd.2014.117 – volume: 7 start-page: 99 year: 2009 ident: CR6 article-title: Pyroptosis: host cell death and inflammation publication-title: Nat. Rev. Microbiol. doi: 10.1038/nrmicro2070 – volume: 157 start-page: 1013 year: 2014 end-page: 1022 ident: CR24 article-title: Mechanisms and functions of inflammasomes publication-title: Cell doi: 10.1016/j.cell.2014.04.007 – volume: 93 start-page: 9833 year: 1996 end-page: 9838 ident: CR12 article-title: Salmonella typhimurium invasion induces apoptosis in infected macrophages publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.93.18.9833 – volume: 8 start-page: 2133 year: 2019 end-page: 2145 ident: CR74 article-title: Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer publication-title: Cancer Med. doi: 10.1002/cam4.2103 – volume: 31 start-page: 84 year: 2015 end-page: 88 ident: CR130 article-title: Targeting apoptosis for anticancer therapy publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2014.05.002 – volume: 27 start-page: 3646 year: 2019 end-page: 3656 ident: CR46 article-title: Cathepsin G Inhibition by Serpinb1 and Serpinb6 Prevents Programmed Necrosis in Neutrophils and Monocytes and Reduces GSDMD-Driven Inflammation publication-title: Cell Rep. doi: 10.1016/j.celrep.2019.05.065 – volume: 27 start-page: 827 year: 2019 ident: CR52 article-title: E2-induced activation of the NLRP3 inflammasome triggers pyroptosis and inhibits autophagy in HCC cells publication-title: Oncol. Res. doi: 10.3727/096504018X15462920753012 – volume: 42 start-page: 273 year: 2013 end-page: 276 ident: CR110 article-title: Pyroptosis induced by zinc oxide nanoparticles in A549 cells publication-title: Wei Sheng Yan Jiu – volume: 7 start-page: 84658 year: 2016 end-page: 84665 ident: CR56 article-title: Pyroptosis is involved in the pathogenesis of human hepatocellular carcinoma publication-title: Oncotarget – volume: 24 start-page: 588 year: 2017 end-page: 596 ident: CR81 article-title: ‘Hints’ in the killer protein gasdermin D: unveiling the secrets of gasdermins driving cell death publication-title: Cell Death Differ doi: 10.1038/cdd.2017.24 – volume: 32 start-page: 171 year: 2011 end-page: 179 ident: CR50 article-title: The Nlrp3 inflammasome: contributions to intestinal homeostasis publication-title: Trends Immunol. doi: 10.1016/j.it.2011.02.002 – volume: 98 start-page: 88 year: 2007 end-page: 95 ident: CR87 article-title: Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer publication-title: Cancer Sci. doi: 10.1111/j.1349-7006.2006.00351.x – volume: 14 start-page: 66 year: 2007 ident: CR38 article-title: Caspase substrates publication-title: Cell Death Differ. doi: 10.1038/sj.cdd.4402059 – volume: 17 start-page: 315 year: 2010 end-page: 327 ident: CR127 article-title: The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins publication-title: Gene Ther. doi: 10.1038/gt.2009.126 – volume: 107 start-page: 21635 year: 2010 end-page: 21640 ident: CR48 article-title: Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1016814108 – volume: 214 start-page: 1351 year: 2017 end-page: 1370 ident: CR80 article-title: NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes publication-title: J. Exp. Med. doi: 10.1084/jem.20150237 – volume: 94 start-page: 1368 year: 2019 end-page: 1377 ident: CR119 article-title: Design and optimize N-substituted EF24 as effective and low toxicity NF-kappaB inhibitor for lung cancer therapy via apoptosis-to-pyroptosis switch publication-title: Chem. Biol. Drug Des. doi: 10.1111/cbdd.13514 – volume: 74 start-page: 105713 year: 2019 ident: CR92 article-title: GSDMD is required for effector CD8(+) T cell responses to lung cancer cells publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2019.105713 – volume: 24 start-page: 74 year: 2019 end-page: 82 ident: CR113 article-title: A thiopyran derivative with low murine toxicity with therapeutic potential on lung cancer acting through a NF-kappaB mediated apoptosis-to-pyroptosis switch publication-title: Apoptosis doi: 10.1007/s10495-018-1499-y – volume: 12 start-page: 925 year: 2019 end-page: 931 ident: CR10 article-title: Activation of pyroptotic cell death pathways in cancer: alternative therapeutic approach publication-title: Transl. Oncol. doi: 10.1016/j.tranon.2019.04.010 – volume: 5 year: 2015 ident: CR112 article-title: Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death publication-title: Sci. Rep. doi: 10.1038/srep16222 – volume: 547 start-page: 99 year: 2017 end-page: 103 ident: CR20 article-title: Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin publication-title: Nature doi: 10.1038/nature22393 – volume: 80 start-page: 1055 year: 2011 end-page: 1087 ident: CR39 article-title: Caspase substrates and cellular remodeling publication-title: Annu. Rev. Biochem. doi: 10.1146/annurev-biochem-061809-121639 – volume: 514 start-page: 187 year: 2014 end-page: 192 ident: CR32 article-title: Inflammatory caspases are innate immune receptors for intracellular LPS publication-title: Nature doi: 10.1038/nature13683 – volume: 8 year: 2017 ident: CR42 article-title: Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death publication-title: Nat. Commun. doi: 10.1038/ncomms14128 – volume: 40 start-page: 13 year: 2008 end-page: 24 ident: CR84 article-title: Differential expression and localisation of gasdermin-like (GSDML), a novel member of the cancer-associated GSDMDC protein family, in neoplastic and non-neoplastic gastric, hepatic, and colon tissues publication-title: Pathology doi: 10.1080/00313020701716250 – volume: 10 year: 2019 ident: CR120 article-title: Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells publication-title: Cell Death Dis. doi: 10.1038/s41419-019-1441-4 – volume: 354 start-page: 765 year: 2016 end-page: 768 ident: CR65 article-title: The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury publication-title: Science doi: 10.1126/science.aaf7532 – volume: 65 start-page: 5165 year: 1997 end-page: 5170 ident: CR14 article-title: The interleukin 1beta-converting enzyme, caspase 1, is activated during Shigella flexneri-induced apoptosis in human monocyte-derived macrophages publication-title: Infect. Immun – volume: 25 start-page: 416 year: 2013 end-page: 424 ident: CR30 article-title: Interleukin-1beta in innate inflammation, autophagy and immunity publication-title: Semin. Immunol. doi: 10.1016/j.smim.2013.10.018 – volume: 11 year: 2016 ident: CR73 article-title: Gasdermin C is upregulated by inactivation of transforming growth factor beta receptor Type II in the presence of mutated apc, promoting colorectal cancer proliferation publication-title: PLoS ONE doi: 10.1371/journal.pone.0166422 – volume: 8 year: 2018 ident: CR114 article-title: Omega-3 docosahexaenoic acid induces pyroptosis cell death in triple-negative breast cancer cells publication-title: Sci. Rep. doi: 10.1038/s41598-018-20422-0 – volume: 3 year: 2007 ident: CR3 article-title: Macrophage activation redirects yersinia-infected host cell death from apoptosis to caspase-1-dependent pyroptosis publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.0030161 – volume: 370 start-page: 38 year: 2008 end-page: 43 ident: CR62 article-title: Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2008.03.026 – volume: 40 start-page: 2648 year: 2018 end-page: 2658 ident: CR71 article-title: Biological functions and clinical significance of the newly identified long noncoding RNA RP185F18.6 in colorectal cancer publication-title: Oncol. Rep. – volume: 9 year: 2014 ident: CR59 article-title: Gasdermin-B promotes invasion and metastasis in breast cancer cells publication-title: PLoS ONE doi: 10.1371/journal.pone.0090099 – volume: 5 year: 2014 ident: CR25 article-title: Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 autoproteolysis and speck formation publication-title: Nat. Commun doi: 10.1038/ncomms4209 – volume: 48 start-page: 261 year: 2009 end-page: 271 ident: CR82 article-title: Distinctive expression and function of four GSDM family genes (GSDMA-D) in normal and malignant upper gastrointestinal epithelium publication-title: Genes Chromosomes Cancer doi: 10.1002/gcc.20636 – volume: 6 start-page: 1263 year: 2014 end-page: 1278 ident: CR111 article-title: The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer publication-title: EMBO Mol. Med. doi: 10.15252/emmm.201404084 – volume: 25 start-page: 486 year: 2018 ident: CR23 article-title: Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 publication-title: Cell Death Differ doi: 10.1038/s41418-017-0012-4 – volume: 111 start-page: 7403 year: 2014 end-page: 7408 ident: CR28 article-title: Inflammasome activation causes dual recruitment of NLRC4 and NLRP3 to the same macromolecular complex publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1402911111 – volume: 194 start-page: 3369 year: 2015 end-page: 3380 ident: CR68 article-title: The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis publication-title: J. Immunol. doi: 10.4049/jimmunol.1402098 – volume: 526 start-page: 666 year: 2015 end-page: 671 ident: CR33 article-title: Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling publication-title: Nature doi: 10.1038/nature15541 – volume: 78 start-page: 6183 year: 2018 end-page: 6195 ident: CR116 article-title: Therapeutically active RIG-I agonist induces immunogenic tumor cell killing in breast cancers publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-18-0730 – volume: 8 start-page: 1812 year: 2006 end-page: 1825 ident: CR4 article-title: Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages publication-title: Cell. Microbiol. doi: 10.1111/j.1462-5822.2006.00751.x – volume: 135 start-page: 2387 year: 2014 end-page: 2396 ident: CR66 article-title: Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients publication-title: Int. J. Cancer doi: 10.1002/ijc.28891 – volume: 6 year: 2015 ident: CR69 article-title: DAC can restore expression of NALP1 to suppress tumor growth in colon cancer publication-title: Cell Death Dis. doi: 10.1038/cddis.2014.532 – volume: 526 start-page: 660 year: 2015 end-page: 665 ident: CR17 article-title: Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death publication-title: Nature doi: 10.1038/nature15514 – volume: 233 start-page: 2116 year: 2018 ident: 1883_CR95 publication-title: J. Cell Physiol doi: 10.1002/jcp.25930 – volume: 40 start-page: 2648 year: 2018 ident: 1883_CR71 publication-title: Oncol. Rep. – volume: 94 start-page: 1368 year: 2019 ident: 1883_CR119 publication-title: Chem. Biol. Drug Des. doi: 10.1111/cbdd.13514 – volume: 92 start-page: 501 year: 1998 ident: 1883_CR35 publication-title: Cell doi: 10.1016/S0092-8674(00)80943-5 – volume: 28 start-page: 1171 year: 2018 ident: 1883_CR128 publication-title: Cell Res. doi: 10.1038/s41422-018-0090-y – volume: 1872 start-page: 1 year: 2019 ident: 1883_CR8 publication-title: Biochim Biophys. Acta Rev. Cancer doi: 10.1016/j.bbcan.2019.05.001 – volume: 202 start-page: 1043 year: 2005 ident: 1883_CR2 publication-title: J. Exp. Med. doi: 10.1084/jem.20050977 – volume: 26 start-page: 146 year: 2019 ident: 1883_CR63 publication-title: Chin. J. Cancer Biother – volume: 98 start-page: 88 year: 2007 ident: 1883_CR87 publication-title: Cancer Sci. doi: 10.1111/j.1349-7006.2006.00351.x – volume: 45 start-page: 1117 year: 2018 ident: 1883_CR9 publication-title: Chin. J. Clin. Oncol. – volume: 535 start-page: 111 year: 2016 ident: 1883_CR18 publication-title: Nature doi: 10.1038/nature18590 – volume: 9 start-page: 64 year: 2001 ident: 1883_CR16 publication-title: Trends Microbio.l doi: 10.1016/S0966-842X(00)01937-5 – volume: 514 start-page: 187 year: 2014 ident: 1883_CR32 publication-title: Nature doi: 10.1038/nature13683 – volume: 7 start-page: 84658 year: 2016 ident: 1883_CR56 publication-title: Oncotarget doi: 10.18632/oncotarget.12384 – volume: 24 start-page: 6066 year: 2018 ident: 1883_CR93 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-18-1478 – volume: 17 start-page: 315 year: 2010 ident: 1883_CR127 publication-title: Gene Ther. doi: 10.1038/gt.2009.126 – volume: 31 start-page: 721727 year: 2015 ident: 1883_CR27 publication-title: Chin. J. Immunol. – volume: 277 start-page: 61 year: 2017 ident: 1883_CR31 publication-title: Immunol. Rev. doi: 10.1111/imr.12534 – volume: 535 start-page: 153 year: 2016 ident: 1883_CR40 publication-title: Nature doi: 10.1038/nature18629 – volume: 51 start-page: 652 year: 2006 ident: 1883_CR64 publication-title: J. Hum. Genet. doi: 10.1007/s10038-006-0004-6 – volume: 6 year: 2015 ident: 1883_CR69 publication-title: Cell Death Dis. doi: 10.1038/cddis.2014.532 – volume: 207 start-page: 1045 year: 2010 ident: 1883_CR49 publication-title: J. Exp. Med. doi: 10.1084/jem.20100050 – volume: 5 year: 2015 ident: 1883_CR112 publication-title: Sci. Rep. doi: 10.1038/srep16222 – volume: 85 start-page: 75 year: 2010 ident: 1883_CR83 publication-title: Genes Genet. Syst. doi: 10.1266/ggs.85.75 – volume: 94 start-page: 52 year: 2014 ident: 1883_CR51 publication-title: Lab Invest. doi: 10.1038/labinvest.2013.126 – volume: 6 start-page: 1263 year: 2014 ident: 1883_CR111 publication-title: EMBO Mol. Med. doi: 10.15252/emmm.201404084 – volume: 27 start-page: 3624 year: 2008 ident: 1883_CR88 publication-title: Oncogene doi: 10.1038/sj.onc.1211021 – volume: 8 start-page: 1812 year: 2006 ident: 1883_CR4 publication-title: Cell. Microbiol. doi: 10.1111/j.1462-5822.2006.00751.x – volume: 495 start-page: 1418 year: 2018 ident: 1883_CR89 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2017.11.156 – volume: 450 start-page: 22 year: 2019 ident: 1883_CR123 publication-title: Cancer Lett doi: 10.1016/j.canlet.2019.02.014 – volume: 354 start-page: 765 year: 2016 ident: 1883_CR65 publication-title: Science doi: 10.1126/science.aaf7532 – volume: 42 start-page: 245 year: 2017 ident: 1883_CR21 publication-title: Trends Biochem. Sci. doi: 10.1016/j.tibs.2016.10.004 – volume: 88 start-page: 535 year: 2000 ident: 1883_CR76 publication-title: Int. J. Cancer doi: 10.1002/1097-0215(20001115)88:4<535::AID-IJC4>3.0.CO;2-V – volume: 42 start-page: 273 year: 2013 ident: 1883_CR110 publication-title: Wei Sheng Yan Jiu – volume: 157 start-page: 1013 year: 2014 ident: 1883_CR24 publication-title: Cell doi: 10.1016/j.cell.2014.04.007 – volume: 78 start-page: 6183 year: 2018 ident: 1883_CR116 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-18-0730 – volume: 17 start-page: 1316 year: 2019 ident: 1883_CR106 publication-title: Mol. Cancer. Res doi: 10.1158/1541-7786.MCR-18-0910 – volume: 92 start-page: 140 year: 2001 ident: 1883_CR75 publication-title: Jpn J. Cancer Res. doi: 10.1111/j.1349-7006.2001.tb01076.x – volume: 8 start-page: 147 year: 2013 ident: 1883_CR19 publication-title: Future Microbiol doi: 10.2217/fmb.12.140 – volume: 27 start-page: 827 year: 2019 ident: 1883_CR52 publication-title: Oncol. Res. doi: 10.3727/096504018X15462920753012 – volume: 11 year: 2012 ident: 1883_CR100 publication-title: Mol. Cancer doi: 10.1186/1476-4598-11-87 – volume: 60 start-page: 1291 year: 2017 ident: 1883_CR122 publication-title: Sci. China Life. Sci. doi: 10.1007/s11427-017-9142-2 – volume: 25 start-page: 486 year: 2018 ident: 1883_CR23 publication-title: Cell Death Differ doi: 10.1038/s41418-017-0012-4 – volume: 11 start-page: 1136 year: 2010 ident: 1883_CR107 publication-title: Nat. Immunol doi: 10.1038/ni.1960 – volume: 207 start-page: 296 year: 2018 ident: 1883_CR94 publication-title: Life Sci doi: 10.1016/j.lfs.2018.06.015 – volume: 40 start-page: 1971 year: 2018 ident: 1883_CR91 publication-title: Oncol. Rep. – volume: 2018 start-page: 2864120 year: 2018 ident: 1883_CR58 publication-title: Biomed. Res. Int. doi: 10.1155/2018/2864120 – volume: 65 start-page: 5165 year: 1997 ident: 1883_CR14 publication-title: Infect. Immun doi: 10.1128/iai.65.12.5165-5170.1997 – volume: 314 start-page: 24 year: 2012 ident: 1883_CR101 publication-title: Cancer Lett doi: 10.1016/j.canlet.2011.10.001 – volume: 5 year: 2014 ident: 1883_CR25 publication-title: Nat. Commun doi: 10.1038/ncomms4209 – volume: 358 start-page: 167 year: 1992 ident: 1883_CR13 publication-title: Nature doi: 10.1038/358167a0 – volume: 8 year: 2018 ident: 1883_CR114 publication-title: Sci. Rep. doi: 10.1038/s41598-018-20422-0 – volume: 370 start-page: 38 year: 2008 ident: 1883_CR62 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2008.03.026 – volume: 430 start-page: 3068 year: 2018 ident: 1883_CR90 publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2018.07.002 – volume: 479 start-page: 117 year: 2011 ident: 1883_CR36 publication-title: Nature doi: 10.1038/nature10558 – volume: 8 year: 2017 ident: 1883_CR42 publication-title: Nat. Commun. doi: 10.1038/ncomms14128 – volume: 31 start-page: 84 year: 2015 ident: 1883_CR130 publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2014.05.002 – volume: 149 start-page: 613 year: 2000 ident: 1883_CR34 publication-title: J. Cell Biol. doi: 10.1083/jcb.149.3.613 – volume: 5 start-page: 12 year: 2014 ident: 1883_CR102 publication-title: Protein Cell doi: 10.1007/s13238-013-0001-4 – volume: 362 start-page: 1064 year: 2018 ident: 1883_CR45 publication-title: Science doi: 10.1126/science.aau2818 – volume: 104 start-page: 913 year: 2019 ident: 1883_CR125 publication-title: Int – volume: 40 start-page: 6525 year: 2013 ident: 1883_CR57 publication-title: Mol. Biol. Rep doi: 10.1007/s11033-013-2581-8 – volume: 74 start-page: 2395 year: 2017 ident: 1883_CR67 publication-title: Cell. Mol. Life Sci. doi: 10.1007/s00018-017-2477-1 – volume: 96 start-page: 2396 year: 1999 ident: 1883_CR15 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.96.5.2396 – volume: 32 start-page: 171 year: 2011 ident: 1883_CR50 publication-title: Trends Immunol. doi: 10.1016/j.it.2011.02.002 – volume: 40 start-page: 13 year: 2008 ident: 1883_CR84 publication-title: Pathology doi: 10.1080/00313020701716250 – volume: 265 start-page: 130 year: 2015 ident: 1883_CR29 publication-title: Immunol. Rev. doi: 10.1111/imr.12287 – volume: 11 year: 2016 ident: 1883_CR73 publication-title: PLoS ONE doi: 10.1371/journal.pone.0166422 – volume: 107 start-page: 21635 year: 2010 ident: 1883_CR48 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1016814108 – volume: 505 start-page: 509 year: 2014 ident: 1883_CR109 publication-title: Nature doi: 10.1038/nature12940 – volume: 24 start-page: 312 year: 2019 ident: 1883_CR121 publication-title: Apoptosis doi: 10.1007/s10495-019-01515-1 – volume: 214 start-page: 1351 year: 2017 ident: 1883_CR80 publication-title: J. Exp. Med. doi: 10.1084/jem.20150237 – volume: 26 start-page: 1007 year: 2016 ident: 1883_CR5 publication-title: Cell Res. doi: 10.1038/cr.2016.100 – volume: 19 start-page: 468 year: 2013 ident: 1883_CR99 publication-title: Cancer J. doi: 10.1097/PPO.0000000000000004 – volume: 48 start-page: 261 year: 2009 ident: 1883_CR82 publication-title: Genes Chromosomes Cancer doi: 10.1002/gcc.20636 – volume: 10 year: 2019 ident: 1883_CR120 publication-title: Cell Death Dis. doi: 10.1038/s41419-019-1441-4 – volume: 19 start-page: 197 year: 2019 ident: 1883_CR26 publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-019-0123-y – volume: 41 start-page: 244 year: 2019 ident: 1883_CR104 publication-title: Ebiomedicine doi: 10.1016/j.ebiom.2019.02.012 – volume: 547 start-page: 99 year: 2017 ident: 1883_CR20 publication-title: Nature doi: 10.1038/nature22393 – volume: 73 start-page: 1907 year: 2005 ident: 1883_CR1 publication-title: Infect. Immun. doi: 10.1128/IAI.73.4.1907-1916.2005 – volume: 10 year: 2018 ident: 1883_CR131 publication-title: Clin. Epigenetics doi: 10.1186/s13148-018-0479-y – volume: 13 start-page: 46 year: 2017 ident: 1883_CR117 publication-title: Nat. Chem. Biol doi: 10.1038/nchembio.2229 – volume: 113 start-page: E4857 year: 2016 ident: 1883_CR54 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1601700113 – volume: 40 start-page: 1237 year: 2019 ident: 1883_CR78 publication-title: Acta Pharmacol. Sin. doi: 10.1038/s41401-019-0222-z – volume: 22 start-page: 62 year: 2017 ident: 1883_CR7 publication-title: J. Cancer Prev. doi: 10.15430/JCP.2017.22.2.62 – volume: 135 start-page: 2387 year: 2014 ident: 1883_CR66 publication-title: Int. J. Cancer doi: 10.1002/ijc.28891 – volume: 38 start-page: 2658 year: 2019 ident: 1883_CR70 publication-title: Oncogene doi: 10.1038/s41388-018-0613-5 – volume: 14 start-page: 406 year: 2018 ident: 1883_CR129 publication-title: Int. J. Biol. Sci. doi: 10.7150/ijbs.23542 – volume: 11 start-page: 718 year: 2000 ident: 1883_CR86 publication-title: Mamm. Genome doi: 10.1007/s003350010138 – volume: 2 start-page: 439 year: 2016 ident: 1883_CR103 publication-title: Cell Mol. Gastroenterol. Hepatol. doi: 10.1016/j.jcmgh.2016.03.006 – volume: 7 start-page: 99 year: 2009 ident: 1883_CR6 publication-title: Nat. Rev. Microbiol. doi: 10.1038/nrmicro2070 – volume: 9 start-page: 880 year: 2010 ident: 1883_CR37 publication-title: Mol. Cell Proteomics doi: 10.1074/mcp.M900528-MCP200 – volume: 93 start-page: 9833 year: 1996 ident: 1883_CR12 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.93.18.9833 – volume: 122 start-page: 699 year: 2010 ident: 1883_CR61 publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-009-0600-1 – volume: 8 year: 2018 ident: 1883_CR79 publication-title: Sci. Rep. doi: 10.1038/s41598-018-21998-3 – volume: 9 start-page: 113 year: 2001 ident: 1883_CR11 publication-title: Trends Microbiol doi: 10.1016/S0966-842X(00)01936-3 – volume: 27 start-page: 3646 year: 2019 ident: 1883_CR46 publication-title: Cell Rep. doi: 10.1016/j.celrep.2019.05.065 – volume: 74 start-page: 105713 year: 2019 ident: 1883_CR92 publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2019.105713 – volume: 56 start-page: 286 year: 2019 ident: 1883_CR115 publication-title: Phytomedicine doi: 10.1016/j.phymed.2018.09.223 – volume: 9 year: 2014 ident: 1883_CR59 publication-title: PLoS ONE doi: 10.1371/journal.pone.0090099 – volume: 4 start-page: 370 year: 2013 ident: 1883_CR98 publication-title: Front. Immunol doi: 10.3389/fimmu.2013.00370 – volume: 8 start-page: 2133 year: 2019 ident: 1883_CR74 publication-title: Cancer Med. doi: 10.1002/cam4.2103 – volume: 22 start-page: 2924 year: 2018 ident: 1883_CR22 publication-title: Cell Rep. doi: 10.1016/j.celrep.2018.02.067 – volume: 32 start-page: 367 year: 2010 ident: 1883_CR47 publication-title: Immunity doi: 10.1016/j.immuni.2010.02.012 – volume: 24 start-page: 74 year: 2019 ident: 1883_CR113 publication-title: Apoptosis doi: 10.1007/s10495-018-1499-y – volume: 86 start-page: 10961 year: 2012 ident: 1883_CR108 publication-title: J. Virol doi: 10.1128/JVI.01275-12 – volume: 32 start-page: 358 year: 2017 ident: 1883_CR97 publication-title: Practical J. Cancer – volume: 526 start-page: 666 year: 2015 ident: 1883_CR33 publication-title: Nature doi: 10.1038/nature15541 – volume: 25 start-page: 416 year: 2013 ident: 1883_CR30 publication-title: Semin. Immunol. doi: 10.1016/j.smim.2013.10.018 – volume: 494 start-page: 54 year: 2001 ident: 1883_CR77 publication-title: FEBS Lett. doi: 10.1016/S0014-5793(01)02304-3 – volume: 25 start-page: 1009 year: 2017 ident: 1883_CR105 publication-title: Oncol. Res. doi: 10.3727/096504016X14813859905646 – volume: 2018 start-page: 5912194 year: 2018 ident: 1883_CR126 publication-title: Stem Cells Int. – volume: 12 start-page: 925 year: 2019 ident: 1883_CR10 publication-title: Transl. Oncol. doi: 10.1016/j.tranon.2019.04.010 – volume: 19 start-page: 74 year: 2018 ident: 1883_CR85 publication-title: J. Dig. Dis. doi: 10.1111/1751-2980.12576 – volume: 111 start-page: 7403 year: 2014 ident: 1883_CR28 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1402911111 – volume: 252 start-page: 169 year: 1998 ident: 1883_CR60 publication-title: Eur. J. Biochem doi: 10.1046/j.1432-1327.1998.2520169.x – volume: 113 start-page: 7858 year: 2016 ident: 1883_CR41 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1607769113 – volume: 21 start-page: 1914 year: 2014 ident: 1883_CR124 publication-title: Cell Death Differ. doi: 10.1038/cdd.2014.117 – volume: 362 start-page: 956 year: 2018 ident: 1883_CR44 publication-title: Science doi: 10.1126/science.aar7607 – volume: 7 start-page: 36185 year: 2016 ident: 1883_CR53 publication-title: Oncotarget doi: 10.18632/oncotarget.9154 – volume: 22 start-page: 8186 year: 2018 ident: 1883_CR55 publication-title: Eur. Rev. Med Pharm. Sci. – volume: 37 start-page: 5191 year: 2018 ident: 1883_CR96 publication-title: Oncogene doi: 10.1038/s41388-018-0339-4 – volume: 14 start-page: 66 year: 2007 ident: 1883_CR38 publication-title: Cell Death Differ. doi: 10.1038/sj.cdd.4402059 – volume: 75 start-page: 3424 year: 2015 ident: 1883_CR72 publication-title: Cancer Res. doi: 10.1158/1538-7445.AM2015-3424 – volume: 526 start-page: 660 year: 2015 ident: 1883_CR17 publication-title: Nature doi: 10.1038/nature15514 – volume: 115 start-page: E10888 year: 2018 ident: 1883_CR43 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1809548115 – volume: 194 start-page: 3369 year: 2015 ident: 1883_CR68 publication-title: J. Immunol. doi: 10.4049/jimmunol.1402098 – volume: 3 year: 2007 ident: 1883_CR3 publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.0030161 – volume: 80 start-page: 1055 year: 2011 ident: 1883_CR39 publication-title: Annu. Rev. Biochem. doi: 10.1146/annurev-biochem-061809-121639 – volume: 24 start-page: 588 year: 2017 ident: 1883_CR81 publication-title: Cell Death Differ doi: 10.1038/cdd.2017.24 – volume: 24 start-page: 1151 year: 2018 ident: 1883_CR118 publication-title: Nat. Med. doi: 10.1038/s41591-018-0082-y |
| SSID | ssj0000330256 |
| Score | 2.6804461 |
| SecondaryResourceType | review_article |
| Snippet | Programmed cell death (PCD) refers to the way in which cells die depending on specific genes encoding signals or activities. Apoptosis, autophagy, and... |
| SourceID | pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 650 |
| SubjectTerms | 13/95 38/77 631/67 692/699/67 Animals Antibodies Apoptosis Apoptosis - genetics Apoptosis - physiology Autophagy Biochemistry Biomedical and Life Sciences Cancer Cancer therapies Cell Biology Cell Culture Cell death Drug resistance Hearing loss Hearing Loss, Sensorineural - genetics Hearing Loss, Sensorineural - metabolism Humans Immune response Immunology Immunosuppressive agents Inflammation Life Sciences mRNA Phagocytosis Pyroptosis Pyroptosis - genetics Pyroptosis - physiology Receptors, Estrogen - genetics Receptors, Estrogen - metabolism Review Review Article RNA, Messenger - metabolism Tumor cells Tumors |
| Title | The role of pyroptosis in cancer: pro-cancer or pro-“host”? |
| URI | https://link.springer.com/article/10.1038/s41419-019-1883-8 https://www.ncbi.nlm.nih.gov/pubmed/31501419 https://www.proquest.com/docview/2304873339 https://www.proquest.com/docview/2288003533 https://pubmed.ncbi.nlm.nih.gov/PMC6733901 |
| Volume | 10 |
| WOSCitedRecordID | wos000494969700009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: M7P dateStart: 20100101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: 7X7 dateStart: 20100101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: BENPR dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: PIMPY dateStart: 20100101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 2041-4889 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000330256 issn: 2041-4889 databaseCode: M2P dateStart: 20100101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3LbtQwcER3QeLC-xEoKyNxAkVNbGdjc1kBagWHriLUw3KK7DzUlVCyJFuk3voh8HP9EmacR7VU9MIho0S25dgz9oxnPDMAbxTyIK7nBhdSHvgSWZ6vbWh9XZqioPCENipdsol4uVSrlU56hVvbX6sc9kS3Ued1RjryA1JeqlgIoRebHz5ljSLrap9CYw-mFKlMTmD68XCZfB21LAEe15GpD-ZMoQ5aGUry28EnVEr4apchXZMyr1-W_Mti6hjR0f3_HcIDuNeLoOxDRzMP4VZRPYI7XVLK88ewQMphdOmQ1SXbnDf1Zlu365atK5YRiTTvGfbrd--sbtzX5cUvche5vPi9eAInR4cnnz77fZoFP4vEfOvbMMplyXmubaAtz_N5lIXWRKXBs5ctApRYImlzLmKK5E2etqooTRBzk3HLC_EUJlVdFc-BWUlutcbF9JOWGytRGLSc6ywrYyGFB8Ew1WnWhyCnTBjfU2cKFyrtsJMidlLCTqo8eDs22XTxN26qvD9MfNovxTa9mnUPXo_FuIjIMmKqoj7DOhy3sUCg6OvBsw7dY28iJNNriK3jHUIYK1CA7t2San3qAnXPsVuUtzx4N5DM1W_9cxAvbh7ES7jLiXjJpqX3YbJtzopXcDv7uV23zQz24lXsoJr1a2Hm1AwIj3lCMEY4Tb4cJ9_-AFHGFEo |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NbtQwEB6VAioX_gtpCxgJLqCoie1snEpohYCqVcuKwx72ZtmJI1ZCyZJsQXvrg8Aj9KX6JMwkm1RLRW89cIiUyE5sx9_82OOZAXilUAbxZGCQkLLAlyjy_MSG1k9y4xyFJ7RR3iSbiEcjNZkkX9bgrPOFoWOVHU9sGHVWprRHvkublyoWQiTD2XefskaRdbVLodHC4sgtfuKSrX53-BHn9zXn-5_GHw78ZVYBP43EYO7bMMpkznmW2CCxPMsGURpaE-UGlxrWBSigI2kzLmIKXE2OpcrlJoi5SbnlTuBnb8BNZOMxnSCLJ3G_pRMIQRpEZzsVareWoSQnIbxCpYSvVqXfJZX28snMv8yzjdTbv_ef_a_7cHepXrP3LT08gDVXPITbbcLNxSMYIlUwOlDJypzNFlU5m5f1tGbTgqUE_2qP4TD99p6VVfN0fvqLXGHOT38PH8P4Ojq_CetFWbinwKwkl2HTxCuUlhsrUdG1nCdpmsdCCg-CbmZ1ugyvTlk-vunGzC-UbsGgEQyawKCVB2_6V2ZtbJGrKu9086yXbKbWF5Pswcu-GBkEWX1M4coTrMORRQcC1XoPnrTo6lsTIZmVQ3w7XsFdX4GCj6-WFNOvTRDyATaLuqQHbzuEXnTrn4PYunoQL2DjYPz5WB8fjo624Q4nuiHbXbID6_PqxD2DW-mP-bSunjeEx0BfM3D_AKgJagQ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6V8hAX3o9AASPBBRRtYjsbBwmtEGVFVVjtoYferNhxxEooWZItaG_9IfBD-Dv9JczkVS0VvfXAIVIiO7Edf_OwxzMD8EKhDOLJOEVCygJfosjzExMaP8lT5yg8oYnyJtlEPJupw8NkvgW_e18YOlbZ88SGUWelpT3yEW1eqlgIkYzy7ljEfHc6WX7zKYMUWVr7dBotRPbd-gcu3-q3e7s41y85n344eP_R7zIM-DYS45VvwiiTOedZYoLE8CwbRzY0aZSnuOwwLkBhHUmTcRFTEGtyMlUuT4OYp5Yb7gR-9hJcjmUUEXF95vNheycQgrSJ3o4q1KiWoSSHIbxCpYSvNiXhGfX27CnNv0y1jQSc3vyP_90tuNGp3exdSye3YcsVd-Bqm4hzfRcmSC2MDlqyMmfLdVUuV2W9qNmiYJbIonrDcMh-e8_Kqnk6Of5JLjInx78m9-DgIjp_H7aLsnAPgRlJrsRpE8dQGp4aiQqw4TyxNo-FFB4E_Sxr24Vdp-wfX3Vj_hdKt8DQCAxNwNDKg1fDK8s25sh5lXf6Odcd-6n16YR78HwoRsZB1qC0cOUR1uHIugOB6r4HD1qkDa2JkMzNIb4db2BwqEBByTdLisWXJjj5GJtFHdOD1z1aT7v1z0E8On8Qz-Aa4lV_2pvtP4brnEiITHrJDmyvqiP3BK7Y76tFXT1taJCBvmDc_gEWYHLR |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+role+of+pyroptosis+in+cancer%3A+pro-cancer+or+pro-%E2%80%9Chost%E2%80%9D%3F&rft.jtitle=Cell+death+%26+disease&rft.au=Xia%2C+Xiaojing&rft.au=Wang%2C+Xin&rft.au=Cheng%2C+Zhe&rft.au=Qin%2C+Wanhai&rft.date=2019-09-09&rft.pub=Springer+Nature+B.V&rft.eissn=2041-4889&rft.volume=10&rft.spage=1&rft.epage=13&rft_id=info:doi/10.1038%2Fs41419-019-1883-8&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon |